MX2011010401A

MX2011010401A - Un metodo para regular la proliferacion y deferenciacion de queratinocitos.

Un metodo para regular la proliferacion y deferenciacion de queratinocitos.

Info

Publication number: MX2011010401A
Authority: MX; Mexico
Prior art keywords: igfbp7; cells; expression; keratinocytes; polypeptide
Prior art date: 2009-04-01

Application number

MX2011010401A

Other languages

English (en)

Spanish (es)

Inventor

Eli Sprecher

Janna Nousbeck

Original Assignee

Rappaport Family Inst Res In The Medical Sciences

Priority date

2009-04-01

Filing date

2010-02-28

Publication date

2012-01-20

2010-02-28 Application filed by Rappaport Family Inst Res In The Medical Sciences filed Critical Rappaport Family Inst Res In The Medical Sciences

2012-01-20 Publication of MX2011010401A publication Critical patent/MX2011010401A/es

Links

238000000034 method Methods 0.000 title abstract description 98
230000035755 proliferation Effects 0.000 title abstract description 47
230000004069 differentiation Effects 0.000 title abstract description 41
230000001105 regulatory effect Effects 0.000 title abstract description 36
102100029228 Insulin-like growth factor-binding protein 7 Human genes 0.000 claims abstract description 293
210000002510 keratinocyte Anatomy 0.000 claims abstract description 142
108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 88
239000003795 chemical substances by application Substances 0.000 claims abstract description 75
102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 68
229920001184 polypeptide Polymers 0.000 claims abstract description 54
230000007170 pathology Effects 0.000 claims abstract description 29
230000003463 hyperproliferative effect Effects 0.000 claims abstract description 28
108010008598 insulin-like growth factor binding protein-related protein 1 Proteins 0.000 claims description 294
201000004681 Psoriasis Diseases 0.000 claims description 52
239000008194 pharmaceutical composition Substances 0.000 claims description 33
238000011282 treatment Methods 0.000 claims description 24
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 19
230000000699 topical effect Effects 0.000 claims description 19
201000011486 lichen planus Diseases 0.000 claims description 18
150000007523 nucleic acids Chemical group 0.000 claims description 18
201000010099 disease Diseases 0.000 claims description 14
201000004624 Dermatitis Diseases 0.000 claims description 13
108091028043 Nucleic acid sequence Proteins 0.000 claims description 13
238000011200 topical administration Methods 0.000 claims description 12
YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 claims description 10
230000001684 chronic effect Effects 0.000 claims description 8
239000003937 drug carrier Substances 0.000 claims description 8
206010035116 pityriasis rubra pilaris Diseases 0.000 claims description 8
150000004492 retinoid derivatives Chemical class 0.000 claims description 8
102000028416 insulin-like growth factor binding Human genes 0.000 claims description 7
108091022911 insulin-like growth factor binding Proteins 0.000 claims description 7
239000011280 coal tar Substances 0.000 claims description 6
150000003710 vitamin D derivatives Chemical class 0.000 claims description 6
229930003316 Vitamin D Natural products 0.000 claims description 5
QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 5
NUZWLKWWNNJHPT-UHFFFAOYSA-N anthralin Chemical compound C1C2=CC=CC(O)=C2C(=O)C2=C1C=CC=C2O NUZWLKWWNNJHPT-UHFFFAOYSA-N 0.000 claims description 5
239000002981 blocking agent Substances 0.000 claims description 5
239000003246 corticosteroid Substances 0.000 claims description 5
229960002311 dithranol Drugs 0.000 claims description 5
239000003018 immunosuppressive agent Substances 0.000 claims description 5
230000002637 immunotoxin Effects 0.000 claims description 5
239000002596 immunotoxin Substances 0.000 claims description 5
229940051026 immunotoxin Drugs 0.000 claims description 5
231100000608 immunotoxin Toxicity 0.000 claims description 5
FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 claims description 5
229960004889 salicylic acid Drugs 0.000 claims description 5
235000019166 vitamin D Nutrition 0.000 claims description 5
239000011710 vitamin D Substances 0.000 claims description 5
229940046008 vitamin d Drugs 0.000 claims description 5
229940122739 Calcineurin inhibitor Drugs 0.000 claims description 4
101710192106 Calcineurin-binding protein cabin-1 Proteins 0.000 claims description 4
102100024123 Calcineurin-binding protein cabin-1 Human genes 0.000 claims description 4
239000003124 biologic agent Substances 0.000 claims description 4
206010012438 Dermatitis atopic Diseases 0.000 claims description 3
206010012442 Dermatitis contact Diseases 0.000 claims description 3
201000008937 atopic dermatitis Diseases 0.000 claims description 3
208000010247 contact dermatitis Diseases 0.000 claims description 3
230000014509 gene expression Effects 0.000 abstract description 114
230000000694 effects Effects 0.000 abstract description 43
102000040430 polynucleotide Human genes 0.000 abstract description 21
108091033319 polynucleotide Proteins 0.000 abstract description 21
239000002157 polynucleotide Substances 0.000 abstract description 21
101000840577 Homo sapiens Insulin-like growth factor-binding protein 7 Proteins 0.000 abstract description 4
210000004027 cell Anatomy 0.000 description 159
108090000623 proteins and genes Proteins 0.000 description 92
239000000203 mixture Substances 0.000 description 84
210000003491 skin Anatomy 0.000 description 69
108020004459 Small interfering RNA Proteins 0.000 description 59
108091032973 (ribonucleotides)n+m Proteins 0.000 description 56
229920001296 polysiloxane Polymers 0.000 description 56
241000282414 Homo sapiens Species 0.000 description 53
108091027967 Small hairpin RNA Proteins 0.000 description 47
239000004055 small Interfering RNA Substances 0.000 description 46
239000002924 silencing RNA Substances 0.000 description 42
239000011575 calcium Substances 0.000 description 35
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 35
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 31
229910052791 calcium Inorganic materials 0.000 description 31
239000000839 emulsion Substances 0.000 description 31
108020004999 messenger RNA Proteins 0.000 description 31
-1 oxygen radical Chemical class 0.000 description 31
102000004169 proteins and genes Human genes 0.000 description 29
239000012071 phase Substances 0.000 description 28
239000003814 drug Substances 0.000 description 27
239000003921 oil Substances 0.000 description 27
235000018102 proteins Nutrition 0.000 description 26
230000006907 apoptotic process Effects 0.000 description 25
239000003995 emulsifying agent Substances 0.000 description 25
230000009368 gene silencing by RNA Effects 0.000 description 25
125000003729 nucleotide group Chemical group 0.000 description 25
235000019198 oils Nutrition 0.000 description 25
239000013598 vector Substances 0.000 description 25
239000013543 active substance Substances 0.000 description 24
150000001413 amino acids Chemical group 0.000 description 24
235000014113 dietary fatty acids Nutrition 0.000 description 24
239000000194 fatty acid Substances 0.000 description 24
229930195729 fatty acid Natural products 0.000 description 24
239000002773 nucleotide Substances 0.000 description 24
210000001519 tissue Anatomy 0.000 description 24
230000003827 upregulation Effects 0.000 description 23
102000040650 (ribonucleotides)n+m Human genes 0.000 description 22
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 21
235000001014 amino acid Nutrition 0.000 description 21
239000012634 fragment Substances 0.000 description 20
239000004480 active ingredient Substances 0.000 description 19
230000003828 downregulation Effects 0.000 description 19
230000030279 gene silencing Effects 0.000 description 19
230000007423 decrease Effects 0.000 description 18
239000002453 shampoo Substances 0.000 description 18
239000000243 solution Substances 0.000 description 18
238000003556 assay Methods 0.000 description 17
241000699666 Mus <mouse, genus> Species 0.000 description 16
108091034117 Oligonucleotide Proteins 0.000 description 16
229940079593 drug Drugs 0.000 description 16
238000002474 experimental method Methods 0.000 description 16
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 16
239000002679 microRNA Substances 0.000 description 16
238000001126 phototherapy Methods 0.000 description 16
102100024193 Mitogen-activated protein kinase 1 Human genes 0.000 description 15
150000001875 compounds Chemical class 0.000 description 15
230000003247 decreasing effect Effects 0.000 description 15
LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 15
239000003974 emollient agent Substances 0.000 description 15
239000013604 expression vector Substances 0.000 description 15
150000004665 fatty acids Chemical class 0.000 description 15
239000002953 phosphate buffered saline Substances 0.000 description 15
230000003612 virological effect Effects 0.000 description 15
230000004663 cell proliferation Effects 0.000 description 14
210000002615 epidermis Anatomy 0.000 description 14
239000007788 liquid Substances 0.000 description 14
239000004094 surface-active agent Substances 0.000 description 14
108010007457 Extracellular Signal-Regulated MAP Kinases Proteins 0.000 description 13
230000000692 anti-sense effect Effects 0.000 description 13
239000002585 base Substances 0.000 description 13
230000033228 biological regulation Effects 0.000 description 13
239000000499 gel Substances 0.000 description 13
230000001965 increasing effect Effects 0.000 description 13
238000002347 injection Methods 0.000 description 13
239000007924 injection Substances 0.000 description 13
239000000463 material Substances 0.000 description 13
102000053642 Catalytic RNA Human genes 0.000 description 12
241000196324 Embryophyta Species 0.000 description 12
102100040247 Tumor necrosis factor Human genes 0.000 description 12
241000700605 Viruses Species 0.000 description 12
230000015572 biosynthetic process Effects 0.000 description 12
230000000295 complement effect Effects 0.000 description 12
239000002609 medium Substances 0.000 description 12
108091070501 miRNA Proteins 0.000 description 12
230000008569 process Effects 0.000 description 12
108090000994 Catalytic RNA Proteins 0.000 description 11
241001465754 Metazoa Species 0.000 description 11
238000004458 analytical method Methods 0.000 description 11
239000002537 cosmetic Substances 0.000 description 11
230000004048 modification Effects 0.000 description 11
238000012986 modification Methods 0.000 description 11
102000039446 nucleic acids Human genes 0.000 description 11
108020004707 nucleic acids Proteins 0.000 description 11
238000002360 preparation method Methods 0.000 description 11
230000004044 response Effects 0.000 description 11
108091092562 ribozyme Proteins 0.000 description 11
230000009758 senescence Effects 0.000 description 11
239000000126 substance Substances 0.000 description 11
WZUVPPKBWHMQCE-UHFFFAOYSA-N Haematoxylin Chemical compound C12=CC(O)=C(O)C=C2CC2(O)C1C1=CC=C(O)C(O)=C1OC2 WZUVPPKBWHMQCE-UHFFFAOYSA-N 0.000 description 10
206010028980 Neoplasm Diseases 0.000 description 10
125000002091 cationic group Chemical group 0.000 description 10
229920001577 copolymer Polymers 0.000 description 10
230000002222 downregulating effect Effects 0.000 description 10
235000011187 glycerol Nutrition 0.000 description 10
230000005764 inhibitory process Effects 0.000 description 10
239000000047 product Substances 0.000 description 10
238000010186 staining Methods 0.000 description 10
239000000725 suspension Substances 0.000 description 10
108020004414 DNA Proteins 0.000 description 9
108091027757 Deoxyribozyme Proteins 0.000 description 9
238000012228 RNA interference-mediated gene silencing Methods 0.000 description 9
108060008682 Tumor Necrosis Factor Proteins 0.000 description 9
238000013461 design Methods 0.000 description 9
230000006870 function Effects 0.000 description 9
238000000338 in vitro Methods 0.000 description 9
238000001727 in vivo Methods 0.000 description 9
230000001404 mediated effect Effects 0.000 description 9
229920001223 polyethylene glycol Polymers 0.000 description 9
230000001185 psoriatic effect Effects 0.000 description 9
210000002966 serum Anatomy 0.000 description 9
229920002545 silicone oil Polymers 0.000 description 9
238000012360 testing method Methods 0.000 description 9
238000013519 translation Methods 0.000 description 9
VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 8
108060003951 Immunoglobulin Proteins 0.000 description 8
102000004877 Insulin Human genes 0.000 description 8
108090001061 Insulin Proteins 0.000 description 8
108010076504 Protein Sorting Signals Proteins 0.000 description 8
239000008346 aqueous phase Substances 0.000 description 8
201000011510 cancer Diseases 0.000 description 8
230000008859 change Effects 0.000 description 8
239000006071 cream Substances 0.000 description 8
239000003623 enhancer Substances 0.000 description 8
102000006602 glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 8
108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 8
102000018358 immunoglobulin Human genes 0.000 description 8
230000001939 inductive effect Effects 0.000 description 8
229940125396 insulin Drugs 0.000 description 8
229920000642 polymer Polymers 0.000 description 8
239000001267 polyvinylpyrrolidone Substances 0.000 description 8
229920000036 polyvinylpyrrolidone Polymers 0.000 description 8
235000013855 polyvinylpyrrolidone Nutrition 0.000 description 8
230000011664 signaling Effects 0.000 description 8
238000007910 systemic administration Methods 0.000 description 8
238000013518 transcription Methods 0.000 description 8
238000001890 transfection Methods 0.000 description 8
108010021625 Immunoglobulin Fragments Proteins 0.000 description 7
102000008394 Immunoglobulin Fragments Human genes 0.000 description 7
108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 7
102000014429 Insulin-like growth factor Human genes 0.000 description 7
241000699670 Mus sp. Species 0.000 description 7
238000011529 RT qPCR Methods 0.000 description 7
238000012288 TUNEL assay Methods 0.000 description 7
230000001640 apoptogenic effect Effects 0.000 description 7
125000004432 carbon atom Chemical group C* 0.000 description 7
239000000969 carrier Substances 0.000 description 7
238000004113 cell culture Methods 0.000 description 7
230000003750 conditioning effect Effects 0.000 description 7
210000004207 dermis Anatomy 0.000 description 7
238000005516 engineering process Methods 0.000 description 7
238000009472 formulation Methods 0.000 description 7
230000000670 limiting effect Effects 0.000 description 7
GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 7
239000002245 particle Substances 0.000 description 7
239000013612 plasmid Substances 0.000 description 7
239000007921 spray Substances 0.000 description 7
239000003381 stabilizer Substances 0.000 description 7
230000035897 transcription Effects 0.000 description 7
239000003981 vehicle Substances 0.000 description 7
FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 6
102100025087 Insulin receptor substrate 1 Human genes 0.000 description 6
102000011782 Keratins Human genes 0.000 description 6
108010076876 Keratins Proteins 0.000 description 6
238000000134 MTT assay Methods 0.000 description 6
231100000002 MTT assay Toxicity 0.000 description 6
239000002202 Polyethylene glycol Substances 0.000 description 6
DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
102000000574 RNA-Induced Silencing Complex Human genes 0.000 description 6
108010016790 RNA-Induced Silencing Complex Proteins 0.000 description 6
241000700159 Rattus Species 0.000 description 6
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 6
239000002280 amphoteric surfactant Substances 0.000 description 6
230000000875 corresponding effect Effects 0.000 description 6
BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 6
IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 6
230000006698 induction Effects 0.000 description 6
208000015181 infectious disease Diseases 0.000 description 6
239000004615 ingredient Substances 0.000 description 6
150000002632 lipids Chemical class 0.000 description 6
239000006210 lotion Substances 0.000 description 6
238000004519 manufacturing process Methods 0.000 description 6
230000037361 pathway Effects 0.000 description 6
239000000546 pharmaceutical excipient Substances 0.000 description 6
230000008488 polyadenylation Effects 0.000 description 6
238000012545 processing Methods 0.000 description 6
RXWNCPJZOCPEPQ-NVWDDTSBSA-N puromycin Chemical compound C1=CC(OC)=CC=C1C[C@H](N)C(=O)N[C@H]1[C@@H](O)[C@H](N2C3=NC=NC(=C3N=C2)N(C)C)O[C@@H]1CO RXWNCPJZOCPEPQ-NVWDDTSBSA-N 0.000 description 6
230000013568 regulation of keratinocyte differentiation Effects 0.000 description 6
230000023650 regulation of keratinocyte proliferation Effects 0.000 description 6
210000004761 scalp Anatomy 0.000 description 6
239000000600 sorbitol Substances 0.000 description 6
210000000434 stratum corneum Anatomy 0.000 description 6
238000003786 synthesis reaction Methods 0.000 description 6
238000013271 transdermal drug delivery Methods 0.000 description 6
238000010361 transduction Methods 0.000 description 6
230000026683 transduction Effects 0.000 description 6
238000012546 transfer Methods 0.000 description 6
230000035899 viability Effects 0.000 description 6
MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 5
108091026890 Coding region Proteins 0.000 description 5
FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 5
WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 5
108010010803 Gelatin Proteins 0.000 description 5
102000003746 Insulin Receptor Human genes 0.000 description 5
108010001127 Insulin Receptor Proteins 0.000 description 5
102000014150 Interferons Human genes 0.000 description 5
108010050904 Interferons Proteins 0.000 description 5
102100031784 Loricrin Human genes 0.000 description 5
102000057297 Pepsin A Human genes 0.000 description 5
108090000284 Pepsin A Proteins 0.000 description 5
229920003171 Poly (ethylene oxide) Polymers 0.000 description 5
229920002472 Starch Polymers 0.000 description 5
239000007983 Tris buffer Substances 0.000 description 5
230000002159 abnormal effect Effects 0.000 description 5
238000010171 animal model Methods 0.000 description 5
239000002518 antifoaming agent Substances 0.000 description 5
238000004422 calculation algorithm Methods 0.000 description 5
229920002678 cellulose Polymers 0.000 description 5
239000001913 cellulose Substances 0.000 description 5
208000035475 disorder Diseases 0.000 description 5
239000000975 dye Substances 0.000 description 5
230000002500 effect on skin Effects 0.000 description 5
238000004520 electroporation Methods 0.000 description 5
239000000284 extract Substances 0.000 description 5
239000008273 gelatin Substances 0.000 description 5
229920000159 gelatin Polymers 0.000 description 5
229940014259 gelatin Drugs 0.000 description 5
235000019322 gelatine Nutrition 0.000 description 5
235000011852 gelatine desserts Nutrition 0.000 description 5
239000003906 humectant Substances 0.000 description 5
230000002209 hydrophobic effect Effects 0.000 description 5
238000011534 incubation Methods 0.000 description 5
229940079322 interferon Drugs 0.000 description 5
239000003550 marker Substances 0.000 description 5
239000011159 matrix material Substances 0.000 description 5
238000001000 micrograph Methods 0.000 description 5
238000010369 molecular cloning Methods 0.000 description 5
238000010172 mouse model Methods 0.000 description 5
210000000822 natural killer cell Anatomy 0.000 description 5
239000013642 negative control Substances 0.000 description 5
239000002674 ointment Substances 0.000 description 5
239000002243 precursor Substances 0.000 description 5
230000009467 reduction Effects 0.000 description 5
238000011160 research Methods 0.000 description 5
239000007787 solid Substances 0.000 description 5
239000000758 substrate Substances 0.000 description 5
208000024891 symptom Diseases 0.000 description 5
239000003760 tallow Substances 0.000 description 5
239000002562 thickening agent Substances 0.000 description 5
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 5
238000011144 upstream manufacturing Methods 0.000 description 5
239000008158 vegetable oil Substances 0.000 description 5
108090000672 Annexin A5 Proteins 0.000 description 4
102000004121 Annexin A5 Human genes 0.000 description 4
108020000948 Antisense Oligonucleotides Proteins 0.000 description 4
UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 4
CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
108010051109 Cell-Penetrating Peptides Proteins 0.000 description 4
102000020313 Cell-Penetrating Peptides Human genes 0.000 description 4
IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
238000002965 ELISA Methods 0.000 description 4
241000282412 Homo Species 0.000 description 4
239000004166 Lanolin Substances 0.000 description 4
206010033733 Papule Diseases 0.000 description 4
240000004808 Saccharomyces cerevisiae Species 0.000 description 4
239000002253 acid Substances 0.000 description 4
239000000443 aerosol Substances 0.000 description 4
239000000427 antigen Substances 0.000 description 4
108091007433 antigens Proteins 0.000 description 4
102000036639 antigens Human genes 0.000 description 4
239000000074 antisense oligonucleotide Substances 0.000 description 4
238000012230 antisense oligonucleotides Methods 0.000 description 4
208000010668 atopic eczema Diseases 0.000 description 4
230000008901 benefit Effects 0.000 description 4
238000001574 biopsy Methods 0.000 description 4
239000001110 calcium chloride Substances 0.000 description 4
235000011148 calcium chloride Nutrition 0.000 description 4
229910001628 calcium chloride Inorganic materials 0.000 description 4
239000002775 capsule Substances 0.000 description 4
229920006317 cationic polymer Polymers 0.000 description 4
238000006243 chemical reaction Methods 0.000 description 4
238000003776 cleavage reaction Methods 0.000 description 4
239000002299 complementary DNA Substances 0.000 description 4
230000001419 dependent effect Effects 0.000 description 4
239000003599 detergent Substances 0.000 description 4
238000011161 development Methods 0.000 description 4
230000018109 developmental process Effects 0.000 description 4
229960003957 dexamethasone Drugs 0.000 description 4
UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 4
MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 4
NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 4
239000002552 dosage form Substances 0.000 description 4
239000008298 dragée Substances 0.000 description 4
230000036566 epidermal hyperplasia Effects 0.000 description 4
235000019441 ethanol Nutrition 0.000 description 4
210000002950 fibroblast Anatomy 0.000 description 4
239000003205 fragrance Substances 0.000 description 4
239000003102 growth factor Substances 0.000 description 4
230000001900 immune effect Effects 0.000 description 4
238000003119 immunoblot Methods 0.000 description 4
238000010348 incorporation Methods 0.000 description 4
229960000598 infliximab Drugs 0.000 description 4
230000002401 inhibitory effect Effects 0.000 description 4
230000010354 integration Effects 0.000 description 4
230000029411 keratinocyte apoptotic process Effects 0.000 description 4
235000019388 lanolin Nutrition 0.000 description 4
229940039717 lanolin Drugs 0.000 description 4
239000002502 liposome Substances 0.000 description 4
108010079309 loricrin Proteins 0.000 description 4
239000012528 membrane Substances 0.000 description 4
239000002736 nonionic surfactant Substances 0.000 description 4
230000037311 normal skin Effects 0.000 description 4
238000004806 packaging method and process Methods 0.000 description 4
230000008506 pathogenesis Effects 0.000 description 4
229940111202 pepsin Drugs 0.000 description 4
238000010647 peptide synthesis reaction Methods 0.000 description 4
230000008823 permeabilization Effects 0.000 description 4
230000026731 phosphorylation Effects 0.000 description 4
238000006366 phosphorylation reaction Methods 0.000 description 4
239000000843 powder Substances 0.000 description 4
150000003839 salts Chemical class 0.000 description 4
230000007017 scission Effects 0.000 description 4
230000011218 segmentation Effects 0.000 description 4
239000002904 solvent Substances 0.000 description 4
235000019698 starch Nutrition 0.000 description 4
UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 4
239000003826 tablet Substances 0.000 description 4
230000008685 targeting Effects 0.000 description 4
238000002560 therapeutic procedure Methods 0.000 description 4
230000032258 transport Effects 0.000 description 4
241001430294 unidentified retrovirus Species 0.000 description 4
235000015112 vegetable and seed oil Nutrition 0.000 description 4
239000013603 viral vector Substances 0.000 description 4
102100022900 Actin, cytoplasmic 1 Human genes 0.000 description 3
108010085238 Actins Proteins 0.000 description 3
108091003079 Bovine Serum Albumin Proteins 0.000 description 3
206010009944 Colon cancer Diseases 0.000 description 3
PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 description 3
108010036949 Cyclosporine Proteins 0.000 description 3
102000004190 Enzymes Human genes 0.000 description 3
108090000790 Enzymes Proteins 0.000 description 3
241000588724 Escherichia coli Species 0.000 description 3
108010008165 Etanercept Proteins 0.000 description 3
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical group C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 3
229920002907 Guar gum Polymers 0.000 description 3
101001044927 Homo sapiens Insulin-like growth factor-binding protein 3 Proteins 0.000 description 3
101000840582 Homo sapiens Insulin-like growth factor-binding protein 6 Proteins 0.000 description 3
101000975474 Homo sapiens Keratin, type I cytoskeletal 10 Proteins 0.000 description 3
101710201824 Insulin receptor substrate 1 Proteins 0.000 description 3
102100022708 Insulin-like growth factor-binding protein 3 Human genes 0.000 description 3
102100029180 Insulin-like growth factor-binding protein 6 Human genes 0.000 description 3
102100034170 Interferon-induced, double-stranded RNA-activated protein kinase Human genes 0.000 description 3
KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
102100023970 Keratin, type I cytoskeletal 10 Human genes 0.000 description 3
FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 3
GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
241000713666 Lentivirus Species 0.000 description 3
206010064000 Lichenoid keratosis Diseases 0.000 description 3
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
241001529936 Murinae Species 0.000 description 3
201000009053 Neurodermatitis Diseases 0.000 description 3
108700020796 Oncogene Proteins 0.000 description 3
102000043276 Oncogene Human genes 0.000 description 3
241000283973 Oryctolagus cuniculus Species 0.000 description 3
108020004511 Recombinant DNA Proteins 0.000 description 3
241000714474 Rous sarcoma virus Species 0.000 description 3
108700009124 Transcription Initiation Site Proteins 0.000 description 3
102000004887 Transforming Growth Factor beta Human genes 0.000 description 3
108090001012 Transforming Growth Factor beta Proteins 0.000 description 3
108091023045 Untranslated Region Proteins 0.000 description 3
208000027418 Wounds and injury Diseases 0.000 description 3
239000000654 additive Substances 0.000 description 3
SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 3
208000026935 allergic disease Diseases 0.000 description 3
230000033115 angiogenesis Effects 0.000 description 3
239000004599 antimicrobial Substances 0.000 description 3
238000003782 apoptosis assay Methods 0.000 description 3
239000007864 aqueous solution Substances 0.000 description 3
239000003212 astringent agent Substances 0.000 description 3
230000004071 biological effect Effects 0.000 description 3
239000004359 castor oil Substances 0.000 description 3
238000001516 cell proliferation assay Methods 0.000 description 3
230000003833 cell viability Effects 0.000 description 3
238000003570 cell viability assay Methods 0.000 description 3
230000010094 cellular senescence Effects 0.000 description 3
229960000541 cetyl alcohol Drugs 0.000 description 3
229960001265 ciclosporin Drugs 0.000 description 3
KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
238000000576 coating method Methods 0.000 description 3
239000003240 coconut oil Substances 0.000 description 3
235000019864 coconut oil Nutrition 0.000 description 3
239000007859 condensation product Substances 0.000 description 3
238000010276 construction Methods 0.000 description 3
125000004122 cyclic group Chemical group 0.000 description 3
238000001514 detection method Methods 0.000 description 3
230000029087 digestion Effects 0.000 description 3
238000012377 drug delivery Methods 0.000 description 3
238000001035 drying Methods 0.000 description 3
230000002255 enzymatic effect Effects 0.000 description 3
229940088598 enzyme Drugs 0.000 description 3
YQGOJNYOYNNSMM-UHFFFAOYSA-N eosin Chemical compound [Na+].OC(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C(O)=C(Br)C=C21 YQGOJNYOYNNSMM-UHFFFAOYSA-N 0.000 description 3
150000002148 esters Chemical class 0.000 description 3
229960000403 etanercept Drugs 0.000 description 3
210000003527 eukaryotic cell Anatomy 0.000 description 3
150000002191 fatty alcohols Chemical class 0.000 description 3
239000012894 fetal calf serum Substances 0.000 description 3
239000006260 foam Substances 0.000 description 3
238000005187 foaming Methods 0.000 description 3
108020001507 fusion proteins Proteins 0.000 description 3
102000037865 fusion proteins Human genes 0.000 description 3
238000001415 gene therapy Methods 0.000 description 3
239000001963 growth medium Substances 0.000 description 3
235000010417 guar gum Nutrition 0.000 description 3
239000000665 guar gum Substances 0.000 description 3
229960002154 guar gum Drugs 0.000 description 3
235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 3
239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 3
229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 3
UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 3
238000012744 immunostaining Methods 0.000 description 3
230000006882 induction of apoptosis Effects 0.000 description 3
239000008101 lactose Substances 0.000 description 3
230000003902 lesion Effects 0.000 description 3
125000005647 linker group Chemical group 0.000 description 3
210000004379 membrane Anatomy 0.000 description 3
229960000485 methotrexate Drugs 0.000 description 3
239000002480 mineral oil Substances 0.000 description 3
235000010446 mineral oil Nutrition 0.000 description 3
GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 3
239000007764 o/w emulsion Substances 0.000 description 3
230000001590 oxidative effect Effects 0.000 description 3
238000007911 parenteral administration Methods 0.000 description 3
230000035515 penetration Effects 0.000 description 3
230000000144 pharmacologic effect Effects 0.000 description 3
230000001124 posttranscriptional effect Effects 0.000 description 3
230000002062 proliferating effect Effects 0.000 description 3
229950010131 puromycin Drugs 0.000 description 3
102000005962 receptors Human genes 0.000 description 3
108020003175 receptors Proteins 0.000 description 3
238000011084 recovery Methods 0.000 description 3
230000002829 reductive effect Effects 0.000 description 3
230000008929 regeneration Effects 0.000 description 3
238000011069 regeneration method Methods 0.000 description 3
230000010076 replication Effects 0.000 description 3
229930002330 retinoic acid Natural products 0.000 description 3
238000012552 review Methods 0.000 description 3
208000017520 skin disease Diseases 0.000 description 3
239000011780 sodium chloride Substances 0.000 description 3
239000007790 solid phase Substances 0.000 description 3
239000008107 starch Substances 0.000 description 3
230000000638 stimulation Effects 0.000 description 3
238000013517 stratification Methods 0.000 description 3
235000000346 sugar Nutrition 0.000 description 3
ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 description 3
230000001225 therapeutic effect Effects 0.000 description 3
GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
QLAJNZSPVITUCQ-UHFFFAOYSA-N 1,3,2-dioxathietane 2,2-dioxide Chemical compound O=S1(=O)OCO1 QLAJNZSPVITUCQ-UHFFFAOYSA-N 0.000 description 2
OYIFNHCXNCRBQI-UHFFFAOYSA-N 2-aminoadipic acid Chemical compound OC(=O)C(N)CCCC(O)=O OYIFNHCXNCRBQI-UHFFFAOYSA-N 0.000 description 2
WRFPVMFCRNYQNR-UHFFFAOYSA-N 2-hydroxyphenylalanine Chemical compound OC(=O)C(N)CC1=CC=CC=C1O WRFPVMFCRNYQNR-UHFFFAOYSA-N 0.000 description 2
125000003504 2-oxazolinyl group Chemical group O1C(=NCC1)* 0.000 description 2
WOVKYSAHUYNSMH-RRKCRQDMSA-N 5-bromodeoxyuridine Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(Br)=C1 WOVKYSAHUYNSMH-RRKCRQDMSA-N 0.000 description 2
KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
102100039645 ADP-ribosylation factor-like protein 4A Human genes 0.000 description 2
244000215068 Acacia senegal Species 0.000 description 2
108090000644 Angiozyme Proteins 0.000 description 2
241000615866 Antho Species 0.000 description 2
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
241000894006 Bacteria Species 0.000 description 2
102100026189 Beta-galactosidase Human genes 0.000 description 2
CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 2
VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
102000014914 Carrier Proteins Human genes 0.000 description 2
108010035532 Collagen Proteins 0.000 description 2
102000008186 Collagen Human genes 0.000 description 2
241000701022 Cytomegalovirus Species 0.000 description 2
230000006820 DNA synthesis Effects 0.000 description 2
101000876610 Dictyostelium discoideum Extracellular signal-regulated kinase 2 Proteins 0.000 description 2
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
239000012824 ERK inhibitor Substances 0.000 description 2
102100031780 Endonuclease Human genes 0.000 description 2
108010042407 Endonucleases Proteins 0.000 description 2
208000035874 Excoriation Diseases 0.000 description 2
241000233866 Fungi Species 0.000 description 2
SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 2
235000010469 Glycine max Nutrition 0.000 description 2
229920000084 Gum arabic Polymers 0.000 description 2
241000711549 Hepacivirus C Species 0.000 description 2
101000886015 Homo sapiens ADP-ribosylation factor-like protein 4A Proteins 0.000 description 2
101001077604 Homo sapiens Insulin receptor substrate 1 Proteins 0.000 description 2
101001076680 Homo sapiens Insulin-induced gene 1 protein Proteins 0.000 description 2
101001052493 Homo sapiens Mitogen-activated protein kinase 1 Proteins 0.000 description 2
101000788548 Homo sapiens Tubulin alpha-4A chain Proteins 0.000 description 2
108010001336 Horseradish Peroxidase Proteins 0.000 description 2
239000004354 Hydroxyethyl cellulose Substances 0.000 description 2
229920000663 Hydroxyethyl cellulose Polymers 0.000 description 2
206010020649 Hyperkeratosis Diseases 0.000 description 2
206010020751 Hypersensitivity Diseases 0.000 description 2
102000017727 Immunoglobulin Variable Region Human genes 0.000 description 2
108010067060 Immunoglobulin Variable Region Proteins 0.000 description 2
102100026818 Inhibin beta E chain Human genes 0.000 description 2
102100025887 Insulin-induced gene 1 protein Human genes 0.000 description 2
108020004684 Internal Ribosome Entry Sites Proteins 0.000 description 2
102100025758 Keratin, type II cytoskeletal 4 Human genes 0.000 description 2
ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 2
101150116870 LORICRIN gene Proteins 0.000 description 2
241000124008 Mammalia Species 0.000 description 2
102100025751 Mothers against decapentaplegic homolog 2 Human genes 0.000 description 2
101710143123 Mothers against decapentaplegic homolog 2 Proteins 0.000 description 2
102100025748 Mothers against decapentaplegic homolog 3 Human genes 0.000 description 2
101710143111 Mothers against decapentaplegic homolog 3 Proteins 0.000 description 2
WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 2
235000021314 Palmitic acid Nutrition 0.000 description 2
108090000526 Papain Proteins 0.000 description 2
208000005775 Parakeratosis Diseases 0.000 description 2
229930182555 Penicillin Natural products 0.000 description 2
JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
239000004264 Petrolatum Substances 0.000 description 2
239000004721 Polyphenylene oxide Substances 0.000 description 2
229920001213 Polysorbate 20 Polymers 0.000 description 2
102000004022 Protein-Tyrosine Kinases Human genes 0.000 description 2
108090000412 Protein-Tyrosine Kinases Proteins 0.000 description 2
241000283984 Rodentia Species 0.000 description 2
238000011579 SCID mouse model Methods 0.000 description 2
206010039509 Scab Diseases 0.000 description 2
108010042291 Serum Response Factor Proteins 0.000 description 2
102100022056 Serum response factor Human genes 0.000 description 2
206010040844 Skin exfoliation Diseases 0.000 description 2
235000021355 Stearic acid Nutrition 0.000 description 2
238000000692 Student's t-test Methods 0.000 description 2
PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
229930006000 Sucrose Natural products 0.000 description 2
210000001744 T-lymphocyte Anatomy 0.000 description 2
108700026226 TATA Box Proteins 0.000 description 2
GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
241000723873 Tobacco mosaic virus Species 0.000 description 2
108020004566 Transfer RNA Proteins 0.000 description 2
102100025239 Tubulin alpha-4A chain Human genes 0.000 description 2
208000025865 Ulcer Diseases 0.000 description 2
102000003990 Urokinase-type plasminogen activator Human genes 0.000 description 2
108090000435 Urokinase-type plasminogen activator Proteins 0.000 description 2
108091008605 VEGF receptors Proteins 0.000 description 2
102000009484 Vascular Endothelial Growth Factor Receptors Human genes 0.000 description 2
108020000999 Viral RNA Proteins 0.000 description 2
208000036142 Viral infection Diseases 0.000 description 2
238000002835 absorbance Methods 0.000 description 2
239000006096 absorbing agent Substances 0.000 description 2
235000010489 acacia gum Nutrition 0.000 description 2
239000000205 acacia gum Substances 0.000 description 2
230000004913 activation Effects 0.000 description 2
125000002252 acyl group Chemical group 0.000 description 2
WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
238000001042 affinity chromatography Methods 0.000 description 2
150000001298 alcohols Chemical class 0.000 description 2
125000000217 alkyl group Chemical group 0.000 description 2
POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
230000007815 allergy Effects 0.000 description 2
150000001408 amides Chemical class 0.000 description 2
125000000539 amino acid group Chemical group 0.000 description 2
230000003321 amplification Effects 0.000 description 2
125000000129 anionic group Chemical group 0.000 description 2
239000003945 anionic surfactant Substances 0.000 description 2
239000003242 anti bacterial agent Substances 0.000 description 2
206010003246 arthritis Diseases 0.000 description 2
239000012298 atmosphere Substances 0.000 description 2
230000002238 attenuated effect Effects 0.000 description 2
108010005774 beta-Galactosidase Proteins 0.000 description 2
239000011230 binding agent Substances 0.000 description 2
108091008324 binding proteins Proteins 0.000 description 2
230000000975 bioactive effect Effects 0.000 description 2
210000004204 blood vessel Anatomy 0.000 description 2
229940046731 calcineurin inhibitors Drugs 0.000 description 2
150000001720 carbohydrates Chemical class 0.000 description 2
229910002092 carbon dioxide Inorganic materials 0.000 description 2
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
235000019438 castor oil Nutrition 0.000 description 2
239000003093 cationic surfactant Substances 0.000 description 2
230000001413 cellular effect Effects 0.000 description 2
239000002738 chelating agent Substances 0.000 description 2
239000003638 chemical reducing agent Substances 0.000 description 2
230000019113 chromatin silencing Effects 0.000 description 2
229920001436 collagen Polymers 0.000 description 2
239000003636 conditioned culture medium Substances 0.000 description 2
239000008406 cosmetic ingredient Substances 0.000 description 2
230000008878 coupling Effects 0.000 description 2
238000010168 coupling process Methods 0.000 description 2
238000005859 coupling reaction Methods 0.000 description 2
229930182912 cyclosporin Natural products 0.000 description 2
210000000805 cytoplasm Anatomy 0.000 description 2
230000006378 damage Effects 0.000 description 2
238000012217 deletion Methods 0.000 description 2
230000037430 deletion Effects 0.000 description 2
239000000412 dendrimer Substances 0.000 description 2
229920000736 dendritic polymer Polymers 0.000 description 2
239000005547 deoxyribonucleotide Substances 0.000 description 2
125000002637 deoxyribonucleotide group Chemical group 0.000 description 2
230000035618 desquamation Effects 0.000 description 2
238000009792 diffusion process Methods 0.000 description 2
239000004205 dimethyl polysiloxane Substances 0.000 description 2
235000013870 dimethyl polysiloxane Nutrition 0.000 description 2
239000006185 dispersion Substances 0.000 description 2
229960000735 docosanol Drugs 0.000 description 2
POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
239000012636 effector Substances 0.000 description 2
238000001962 electrophoresis Methods 0.000 description 2
230000001804 emulsifying effect Effects 0.000 description 2
230000007613 environmental effect Effects 0.000 description 2
210000001339 epidermal cell Anatomy 0.000 description 2
210000005175 epidermal keratinocyte Anatomy 0.000 description 2
RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
238000011156 evaluation Methods 0.000 description 2
239000010685 fatty oil Substances 0.000 description 2
239000000945 filler Substances 0.000 description 2
210000001035 gastrointestinal tract Anatomy 0.000 description 2
230000002068 genetic effect Effects 0.000 description 2
ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
150000002334 glycols Chemical class 0.000 description 2
229930182470 glycoside Natural products 0.000 description 2
239000008187 granular material Substances 0.000 description 2
230000007062 hydrolysis Effects 0.000 description 2
238000006460 hydrolysis reaction Methods 0.000 description 2
125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
235000019447 hydroxyethyl cellulose Nutrition 0.000 description 2
VAMFXQBUQXONLZ-UHFFFAOYSA-N icos-1-ene Chemical compound CCCCCCCCCCCCCCCCCCC=C VAMFXQBUQXONLZ-UHFFFAOYSA-N 0.000 description 2
BTFJIXJJCSYFAL-UHFFFAOYSA-N icosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 2
238000010191 image analysis Methods 0.000 description 2
238000003018 immunoassay Methods 0.000 description 2
230000008676 import Effects 0.000 description 2
230000006872 improvement Effects 0.000 description 2
238000000099 in vitro assay Methods 0.000 description 2
239000012678 infectious agent Substances 0.000 description 2
230000002458 infectious effect Effects 0.000 description 2
230000000977 initiatory effect Effects 0.000 description 2
208000014674 injury Diseases 0.000 description 2
230000003993 interaction Effects 0.000 description 2
108010033564 involucrin Proteins 0.000 description 2
230000037427 ion transport Effects 0.000 description 2
238000001638 lipofection Methods 0.000 description 2
HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
230000014759 maintenance of location Effects 0.000 description 2
210000004962 mammalian cell Anatomy 0.000 description 2
238000007726 management method Methods 0.000 description 2
238000002844 melting Methods 0.000 description 2
230000008018 melting Effects 0.000 description 2
229920000609 methyl cellulose Polymers 0.000 description 2
ZAZKJZBWRNNLDS-UHFFFAOYSA-N methyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OC ZAZKJZBWRNNLDS-UHFFFAOYSA-N 0.000 description 2
235000010981 methylcellulose Nutrition 0.000 description 2
239000001923 methylcellulose Substances 0.000 description 2
239000004530 micro-emulsion Substances 0.000 description 2
238000002156 mixing Methods 0.000 description 2
230000004660 morphological change Effects 0.000 description 2
VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 2
WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 2
108091027963 non-coding RNA Proteins 0.000 description 2
102000042567 non-coding RNA Human genes 0.000 description 2
238000010606 normalization Methods 0.000 description 2
238000003199 nucleic acid amplification method Methods 0.000 description 2
QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
239000003960 organic solvent Substances 0.000 description 2
230000036961 partial effect Effects 0.000 description 2
230000000149 penetrating effect Effects 0.000 description 2
229940049954 penicillin Drugs 0.000 description 2
239000000816 peptidomimetic Substances 0.000 description 2
235000019271 petrolatum Nutrition 0.000 description 2
229940066842 petrolatum Drugs 0.000 description 2
238000002135 phase contrast microscopy Methods 0.000 description 2
YBYRMVIVWMBXKQ-UHFFFAOYSA-N phenylmethanesulfonyl fluoride Chemical compound FS(=O)(=O)CC1=CC=CC=C1 YBYRMVIVWMBXKQ-UHFFFAOYSA-N 0.000 description 2
239000000049 pigment Substances 0.000 description 2
229920003023 plastic Polymers 0.000 description 2
239000004033 plastic Substances 0.000 description 2
229920000435 poly(dimethylsiloxane) Polymers 0.000 description 2
229920000570 polyether Polymers 0.000 description 2
235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 2
239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 2
230000032361 posttranscriptional gene silencing Effects 0.000 description 2
239000003755 preservative agent Substances 0.000 description 2
230000002265 prevention Effects 0.000 description 2
125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
230000001737 promoting effect Effects 0.000 description 2
239000003380 propellant Substances 0.000 description 2
BEKZXQKGTDVSKX-UHFFFAOYSA-N propyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCCC BEKZXQKGTDVSKX-UHFFFAOYSA-N 0.000 description 2
238000001742 protein purification Methods 0.000 description 2
230000002797 proteolythic effect Effects 0.000 description 2
ZCCUUQDIBDJBTK-UHFFFAOYSA-N psoralen Chemical compound C1=C2OC(=O)C=CC2=CC2=C1OC=C2 ZCCUUQDIBDJBTK-UHFFFAOYSA-N 0.000 description 2
238000000746 purification Methods 0.000 description 2
238000011002 quantification Methods 0.000 description 2
BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 2
230000001177 retroviral effect Effects 0.000 description 2
239000000523 sample Substances 0.000 description 2
230000028327 secretion Effects 0.000 description 2
230000035807 sensation Effects 0.000 description 2
238000000926 separation method Methods 0.000 description 2
239000007901 soft capsule Substances 0.000 description 2
241000894007 species Species 0.000 description 2
230000000087 stabilizing effect Effects 0.000 description 2
239000008117 stearic acid Substances 0.000 description 2
229960005322 streptomycin Drugs 0.000 description 2
239000005720 sucrose Substances 0.000 description 2
150000005846 sugar alcohols Polymers 0.000 description 2
150000008163 sugars Chemical class 0.000 description 2
230000001629 suppression Effects 0.000 description 2
239000000454 talc Substances 0.000 description 2
229910052623 talc Inorganic materials 0.000 description 2
235000012222 talc Nutrition 0.000 description 2
238000011191 terminal modification Methods 0.000 description 2
230000008719 thickening Effects 0.000 description 2
239000010936 titanium Substances 0.000 description 2
231100000419 toxicity Toxicity 0.000 description 2
230000001988 toxicity Effects 0.000 description 2
230000002103 transcriptional effect Effects 0.000 description 2
238000012033 transcriptional gene silencing Methods 0.000 description 2
230000009466 transformation Effects 0.000 description 2
230000009261 transgenic effect Effects 0.000 description 2
229960001727 tretinoin Drugs 0.000 description 2
GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical class CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
241000701161 unidentified adenovirus Species 0.000 description 2
229960005356 urokinase Drugs 0.000 description 2
229940124676 vascular endothelial growth factor receptor Drugs 0.000 description 2
230000009385 viral infection Effects 0.000 description 2
210000002845 virion Anatomy 0.000 description 2
229930003231 vitamin Natural products 0.000 description 2
239000011782 vitamin Substances 0.000 description 2
235000013343 vitamin Nutrition 0.000 description 2
229940088594 vitamin Drugs 0.000 description 2
238000005406 washing Methods 0.000 description 2
239000001993 wax Substances 0.000 description 2
239000002888 zwitterionic surfactant Substances 0.000 description 2
WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 description 1
NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 description 1
DIGQNXIGRZPYDK-WKSCXVIASA-N (2R)-6-amino-2-[[2-[[(2S)-2-[[2-[[(2R)-2-[[(2S)-2-[[(2R,3S)-2-[[2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S,3S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2R)-2-[[2-[[2-[[2-[(2-amino-1-hydroxyethylidene)amino]-3-carboxy-1-hydroxypropylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxybutylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1,5-dihydroxy-5-iminopentylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxybutylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxyethylidene]amino]hexanoic acid Chemical compound C[C@@H]([C@@H](C(=N[C@@H](CS)C(=N[C@@H](C)C(=N[C@@H](CO)C(=NCC(=N[C@@H](CCC(=N)O)C(=NC(CS)C(=N[C@H]([C@H](C)O)C(=N[C@H](CS)C(=N[C@H](CO)C(=NCC(=N[C@H](CS)C(=NCC(=N[C@H](CCCCN)C(=O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)N=C([C@H](CS)N=C([C@H](CO)N=C([C@H](CO)N=C([C@H](C)N=C(CN=C([C@H](CO)N=C([C@H](CS)N=C(CN=C(C(CS)N=C(C(CC(=O)O)N=C(CN)O)O)O)O)O)O)O)O)O)O)O)O DIGQNXIGRZPYDK-WKSCXVIASA-N 0.000 description 1
MRAMPOPITCOOIN-VIFPVBQESA-N (2r)-n-(3-ethoxypropyl)-2,4-dihydroxy-3,3-dimethylbutanamide Chemical compound CCOCCCNC(=O)[C@H](O)C(C)(C)CO MRAMPOPITCOOIN-VIFPVBQESA-N 0.000 description 1
JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
LPMBTLLQQJBUOO-KTKRTIGZSA-N (z)-n,n-bis(2-hydroxyethyl)octadec-9-enamide Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)N(CCO)CCO LPMBTLLQQJBUOO-KTKRTIGZSA-N 0.000 description 1
DDMOUSALMHHKOS-UHFFFAOYSA-N 1,2-dichloro-1,1,2,2-tetrafluoroethane Chemical compound FC(F)(Cl)C(F)(F)Cl DDMOUSALMHHKOS-UHFFFAOYSA-N 0.000 description 1
NNOKXWHHOOMPPR-UHFFFAOYSA-N 1-ethenyl-1h-imidazol-1-ium;trichloride Chemical compound [Cl-].[Cl-].[Cl-].C=C[NH+]1C=CN=C1.C=C[NH+]1C=CN=C1.C=C[NH+]1C=CN=C1 NNOKXWHHOOMPPR-UHFFFAOYSA-N 0.000 description 1
JOLQKTGDSGKSKJ-UHFFFAOYSA-N 1-ethoxypropan-2-ol Chemical compound CCOCC(C)O JOLQKTGDSGKSKJ-UHFFFAOYSA-N 0.000 description 1
XOQABDOICLHPIS-UHFFFAOYSA-N 1-hydroxy-2,1-benzoxaborole Chemical compound C1=CC=C2B(O)OCC2=C1 XOQABDOICLHPIS-UHFFFAOYSA-N 0.000 description 1
IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
PFFANLXVTHIIBE-UHFFFAOYSA-N 1-methyl-4-pyridin-4-ylpyridin-1-ium Chemical class C1=C[N+](C)=CC=C1C1=CC=NC=C1 PFFANLXVTHIIBE-UHFFFAOYSA-N 0.000 description 1
102100022586 17-beta-hydroxysteroid dehydrogenase type 2 Human genes 0.000 description 1
RPZANUYHRMRTTE-UHFFFAOYSA-N 2,3,4-trimethoxy-6-(methoxymethyl)-5-[3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxyoxane;1-[[3,4,5-tris(2-hydroxybutoxy)-6-[4,5,6-tris(2-hydroxybutoxy)-2-(2-hydroxybutoxymethyl)oxan-3-yl]oxyoxan-2-yl]methoxy]butan-2-ol Chemical compound COC1C(OC)C(OC)C(COC)OC1OC1C(OC)C(OC)C(OC)OC1COC.CCC(O)COC1C(OCC(O)CC)C(OCC(O)CC)C(COCC(O)CC)OC1OC1C(OCC(O)CC)C(OCC(O)CC)C(OCC(O)CC)OC1COCC(O)CC RPZANUYHRMRTTE-UHFFFAOYSA-N 0.000 description 1
LDGWQMRUWMSZIU-LQDDAWAPSA-M 2,3-bis[(z)-octadec-9-enoxy]propyl-trimethylazanium;chloride Chemical compound [Cl-].CCCCCCCC\C=C/CCCCCCCCOCC(C[N+](C)(C)C)OCCCCCCCC\C=C/CCCCCCCC LDGWQMRUWMSZIU-LQDDAWAPSA-M 0.000 description 1
JKNCOURZONDCGV-UHFFFAOYSA-N 2-(dimethylamino)ethyl 2-methylprop-2-enoate Chemical compound CN(C)CCOC(=O)C(C)=C JKNCOURZONDCGV-UHFFFAOYSA-N 0.000 description 1
HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 1
XVJSTCOYGMBYPE-UHFFFAOYSA-N 2-aminoethanol;dodecanoic acid Chemical compound NCCO.CCCCCCCCCCCC(O)=O XVJSTCOYGMBYPE-UHFFFAOYSA-N 0.000 description 1
POAOYUHQDCAZBD-UHFFFAOYSA-N 2-butoxyethanol Chemical compound CCCCOCCO POAOYUHQDCAZBD-UHFFFAOYSA-N 0.000 description 1
MPNXSZJPSVBLHP-UHFFFAOYSA-N 2-chloro-n-phenylpyridine-3-carboxamide Chemical compound ClC1=NC=CC=C1C(=O)NC1=CC=CC=C1 MPNXSZJPSVBLHP-UHFFFAOYSA-N 0.000 description 1
ZNQVEEAIQZEUHB-UHFFFAOYSA-N 2-ethoxyethanol Chemical compound CCOCCO ZNQVEEAIQZEUHB-UHFFFAOYSA-N 0.000 description 1
HZLCGUXUOFWCCN-UHFFFAOYSA-N 2-hydroxynonadecane-1,2,3-tricarboxylic acid Chemical compound CCCCCCCCCCCCCCCCC(C(O)=O)C(O)(C(O)=O)CC(O)=O HZLCGUXUOFWCCN-UHFFFAOYSA-N 0.000 description 1
DUIOKRXOKLLURE-UHFFFAOYSA-N 2-octylphenol Chemical compound CCCCCCCCC1=CC=CC=C1O DUIOKRXOKLLURE-UHFFFAOYSA-N 0.000 description 1
AZKSAVLVSZKNRD-UHFFFAOYSA-M 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide Chemical compound [Br-].S1C(C)=C(C)N=C1[N+]1=NC(C=2C=CC=CC=2)=NN1C1=CC=CC=C1 AZKSAVLVSZKNRD-UHFFFAOYSA-M 0.000 description 1
WEVYNIUIFUYDGI-UHFFFAOYSA-N 3-[6-[4-(trifluoromethoxy)anilino]-4-pyrimidinyl]benzamide Chemical compound NC(=O)C1=CC=CC(C=2N=CN=C(NC=3C=CC(OC(F)(F)F)=CC=3)C=2)=C1 WEVYNIUIFUYDGI-UHFFFAOYSA-N 0.000 description 1
MXRGSJAOLKBZLU-UHFFFAOYSA-N 3-ethenylazepan-2-one Chemical compound C=CC1CCCCNC1=O MXRGSJAOLKBZLU-UHFFFAOYSA-N 0.000 description 1
NJLKZOZYTRRDBO-UHFFFAOYSA-N 3-iodopropyl n-butylcarbamate Chemical compound CCCCNC(=O)OCCCI NJLKZOZYTRRDBO-UHFFFAOYSA-N 0.000 description 1
XDMBIDYMRMMSQN-UHFFFAOYSA-N 3-methyloxepane Chemical compound CC1CCCCOC1 XDMBIDYMRMMSQN-UHFFFAOYSA-N 0.000 description 1
VXGRJERITKFWPL-UHFFFAOYSA-N 4',5'-Dihydropsoralen Natural products C1=C2OC(=O)C=CC2=CC2=C1OCC2 VXGRJERITKFWPL-UHFFFAOYSA-N 0.000 description 1
FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 description 1
OPIFSICVWOWJMJ-AEOCFKNESA-N 5-bromo-4-chloro-3-indolyl beta-D-galactoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=CNC2=CC=C(Br)C(Cl)=C12 OPIFSICVWOWJMJ-AEOCFKNESA-N 0.000 description 1
MJZJYWCQPMNPRM-UHFFFAOYSA-N 6,6-dimethyl-1-[3-(2,4,5-trichlorophenoxy)propoxy]-1,6-dihydro-1,3,5-triazine-2,4-diamine Chemical compound CC1(C)N=C(N)N=C(N)N1OCCCOC1=CC(Cl)=C(Cl)C=C1Cl MJZJYWCQPMNPRM-UHFFFAOYSA-N 0.000 description 1
102100036512 7-dehydrocholesterol reductase Human genes 0.000 description 1
LPEKGGXMPWTOCB-UHFFFAOYSA-N 8beta-(2,3-epoxy-2-methylbutyryloxy)-14-acetoxytithifolin Natural products COC(=O)C(C)O LPEKGGXMPWTOCB-UHFFFAOYSA-N 0.000 description 1
102100024381 AF4/FMR2 family member 4 Human genes 0.000 description 1
206010000349 Acanthosis Diseases 0.000 description 1
206010069754 Acquired gene mutation Diseases 0.000 description 1
208000015602 Actinic lichen planus Diseases 0.000 description 1
108010059616 Activins Proteins 0.000 description 1
102100040152 Adenylyl-sulfate kinase Human genes 0.000 description 1
102100026443 Adhesion G-protein coupled receptor F1 Human genes 0.000 description 1
229920001817 Agar Polymers 0.000 description 1
102100022279 Aldehyde dehydrogenase family 3 member B2 Human genes 0.000 description 1
102100024090 Aldo-keto reductase family 1 member C3 Human genes 0.000 description 1
POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
244000144927 Aloe barbadensis Species 0.000 description 1
235000002961 Aloe barbadensis Nutrition 0.000 description 1
102100031969 Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 1 Human genes 0.000 description 1
102100039160 Amiloride-sensitive amine oxidase [copper-containing] Human genes 0.000 description 1
QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
102100039181 Ankyrin repeat domain-containing protein 1 Human genes 0.000 description 1
102000000412 Annexin Human genes 0.000 description 1
108050008874 Annexin Proteins 0.000 description 1
102100028117 Annexin A10 Human genes 0.000 description 1
208000015609 Annular lichen planus Diseases 0.000 description 1
102100021253 Antileukoproteinase Human genes 0.000 description 1
108020005544 Antisense RNA Proteins 0.000 description 1
102100021569 Apoptosis regulator Bcl-2 Human genes 0.000 description 1
108010039627 Aprotinin Proteins 0.000 description 1
102000004363 Aquaporin 3 Human genes 0.000 description 1
108090000991 Aquaporin 3 Proteins 0.000 description 1
102100023650 Aquaporin-11 Human genes 0.000 description 1
101100339431 Arabidopsis thaliana HMGB2 gene Proteins 0.000 description 1
241000233788 Arecaceae Species 0.000 description 1
102100032306 Aurora kinase B Human genes 0.000 description 1
108091032955 Bacterial small RNA Proteins 0.000 description 1
108700003785 Baculoviral IAP Repeat-Containing 3 Proteins 0.000 description 1
102100021662 Baculoviral IAP repeat-containing protein 3 Human genes 0.000 description 1
102100039848 Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 3 Human genes 0.000 description 1
KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
101150104237 Birc3 gene Proteins 0.000 description 1
241000283725 Bos Species 0.000 description 1
241000283690 Bos taurus Species 0.000 description 1
241000701822 Bovine papillomavirus Species 0.000 description 1
206010006187 Breast cancer Diseases 0.000 description 1
102100021935 C-C motif chemokine 26 Human genes 0.000 description 1
102100031168 CCN family member 2 Human genes 0.000 description 1
102100022002 CD59 glycoprotein Human genes 0.000 description 1
102100027217 CD82 antigen Human genes 0.000 description 1
102100036364 Cadherin-2 Human genes 0.000 description 1
102100029761 Cadherin-5 Human genes 0.000 description 1
101100297347 Caenorhabditis elegans pgl-3 gene Proteins 0.000 description 1
101100408682 Caenorhabditis elegans pmt-2 gene Proteins 0.000 description 1
241000282465 Canis Species 0.000 description 1
241000282472 Canis lupus familiaris Species 0.000 description 1
239000004215 Carbon black (E152) Substances 0.000 description 1
102100033040 Carbonic anhydrase 12 Human genes 0.000 description 1
102100030621 Carboxypeptidase A4 Human genes 0.000 description 1
208000024172 Cardiovascular disease Diseases 0.000 description 1
241000701489 Cauliflower mosaic virus Species 0.000 description 1
102100034786 Cell migration-inducing and hyaluronan-binding protein Human genes 0.000 description 1
102100038504 Cellular retinoic acid-binding protein 2 Human genes 0.000 description 1
102100037631 Centrin-2 Human genes 0.000 description 1
102100031219 Centrosomal protein of 55 kDa Human genes 0.000 description 1
101710092479 Centrosomal protein of 55 kDa Proteins 0.000 description 1
LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 1
NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
208000017667 Chronic Disease Diseases 0.000 description 1
208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 description 1
241000723346 Cinnamomum camphora Species 0.000 description 1
102100026096 Claudin-8 Human genes 0.000 description 1
102000012422 Collagen Type I Human genes 0.000 description 1
108010022452 Collagen Type I Proteins 0.000 description 1
102100031457 Collagen alpha-1(V) chain Human genes 0.000 description 1
102100027995 Collagenase 3 Human genes 0.000 description 1
208000035473 Communicable disease Diseases 0.000 description 1
108020004394 Complementary RNA Proteins 0.000 description 1
108010062580 Concanavalin A Proteins 0.000 description 1
108091035707 Consensus sequence Proteins 0.000 description 1
229920002261 Corn starch Polymers 0.000 description 1
102100027309 Cyclic AMP-responsive element-binding protein 5 Human genes 0.000 description 1
108010069514 Cyclic Peptides Proteins 0.000 description 1
102000001189 Cyclic Peptides Human genes 0.000 description 1
229930105110 Cyclosporin A Natural products 0.000 description 1
102100035300 Cystine/glutamate transporter Human genes 0.000 description 1
102100040626 Cytosolic phospholipase A2 gamma Human genes 0.000 description 1
FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
102100024829 DNA polymerase delta catalytic subunit Human genes 0.000 description 1
102100040792 DNA primase small subunit Human genes 0.000 description 1
102100033587 DNA topoisomerase 2-alpha Human genes 0.000 description 1
108090000626 DNA-directed RNA polymerases Proteins 0.000 description 1
102000004163 DNA-directed RNA polymerases Human genes 0.000 description 1
102100036504 Dehydrogenase/reductase SDR family member 9 Human genes 0.000 description 1
241000702421 Dependoparvovirus Species 0.000 description 1
229920002307 Dextran Polymers 0.000 description 1
239000004338 Dichlorodifluoromethane Substances 0.000 description 1
102100030074 Dickkopf-related protein 1 Human genes 0.000 description 1
LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 1
108010016626 Dipeptides Proteins 0.000 description 1
102100027043 Discoidin, CUB and LCCL domain-containing protein 2 Human genes 0.000 description 1
102100031116 Disintegrin and metalloproteinase domain-containing protein 19 Human genes 0.000 description 1
102100029715 DnaJ homolog subfamily A member 4 Human genes 0.000 description 1
101710167313 Drebrin-like protein Proteins 0.000 description 1
102100037573 Dual specificity protein phosphatase 12 Human genes 0.000 description 1
239000006144 Dulbecco’s modiﬁed Eagle's medium Substances 0.000 description 1
102000012078 E2F2 Transcription Factor Human genes 0.000 description 1
108010036466 E2F2 Transcription Factor Proteins 0.000 description 1
102100023227 E3 SUMO-protein ligase EGR2 Human genes 0.000 description 1
102100034597 E3 ubiquitin-protein ligase TRIM22 Human genes 0.000 description 1
102100029520 E3 ubiquitin-protein ligase TRIM31 Human genes 0.000 description 1
102100039577 ETS translocation variant 5 Human genes 0.000 description 1
239000001692 EU approved anti-caking agent Substances 0.000 description 1
LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 description 1
241000792859 Enema Species 0.000 description 1
IMROMDMJAWUWLK-UHFFFAOYSA-N Ethenol Chemical group OC=C IMROMDMJAWUWLK-UHFFFAOYSA-N 0.000 description 1
239000005770 Eugenol Substances 0.000 description 1
241000206602 Eukaryota Species 0.000 description 1
208000010201 Exanthema Diseases 0.000 description 1
102100038638 FYVE, RhoGEF and PH domain-containing protein 3 Human genes 0.000 description 1
102100040777 Fibrinogen C domain-containing protein 1 Human genes 0.000 description 1
102100027842 Fibroblast growth factor receptor 3 Human genes 0.000 description 1
101710182396 Fibroblast growth factor receptor 3 Proteins 0.000 description 1
102000012673 Follicle Stimulating Hormone Human genes 0.000 description 1
108010079345 Follicle Stimulating Hormone Proteins 0.000 description 1
102000016970 Follistatin Human genes 0.000 description 1
108010014612 Follistatin Proteins 0.000 description 1
102100021261 Frizzled-10 Human genes 0.000 description 1
102100037759 GRB2-associated-binding protein 2 Human genes 0.000 description 1
208000034826 Genetic Predisposition to Disease Diseases 0.000 description 1
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
102100033398 Glutamate-cysteine ligase regulatory subunit Human genes 0.000 description 1
102100024017 Glycerol-3-phosphate acyltransferase 3 Human genes 0.000 description 1
244000068988 Glycine max Species 0.000 description 1
208000009329 Graft vs Host Disease Diseases 0.000 description 1
102100028541 Guanylate-binding protein 2 Human genes 0.000 description 1
102100021385 H/ACA ribonucleoprotein complex subunit 1 Human genes 0.000 description 1
102100030595 HLA class II histocompatibility antigen gamma chain Human genes 0.000 description 1
102100031258 HLA class II histocompatibility antigen, DM beta chain Human genes 0.000 description 1
102100029966 HLA class II histocompatibility antigen, DP alpha 1 chain Human genes 0.000 description 1
102100040505 HLA class II histocompatibility antigen, DR alpha chain Human genes 0.000 description 1
102100040482 HLA class II histocompatibility antigen, DR beta 3 chain Human genes 0.000 description 1
102100028636 HLA class II histocompatibility antigen, DR beta 4 chain Human genes 0.000 description 1
108010050568 HLA-DM antigens Proteins 0.000 description 1
108010093061 HLA-DPA1 antigen Proteins 0.000 description 1
108010067802 HLA-DR alpha-Chains Proteins 0.000 description 1
108010061311 HLA-DRB3 Chains Proteins 0.000 description 1
108010040960 HLA-DRB4 Chains Proteins 0.000 description 1
108700010013 HMGB1 Proteins 0.000 description 1
101150021904 HMGB1 gene Proteins 0.000 description 1
239000012981 Hank's balanced salt solution Substances 0.000 description 1
102100040408 Heat shock 70 kDa protein 1-like Human genes 0.000 description 1
102100040352 Heat shock 70 kDa protein 1A Human genes 0.000 description 1
102100040407 Heat shock 70 kDa protein 1B Human genes 0.000 description 1
102100028761 Heat shock 70 kDa protein 6 Human genes 0.000 description 1
102100031624 Heat shock protein 105 kDa Human genes 0.000 description 1
208000002250 Hematologic Neoplasms Diseases 0.000 description 1
102100021519 Hemoglobin subunit beta Human genes 0.000 description 1
108091005904 Hemoglobin subunit beta Proteins 0.000 description 1
102100023934 Heparan sulfate glucosamine 3-O-sulfotransferase 2 Human genes 0.000 description 1
208000005176 Hepatitis C Diseases 0.000 description 1
241000238631 Hexapoda Species 0.000 description 1
102100037907 High mobility group protein B1 Human genes 0.000 description 1
102100034523 Histone H4 Human genes 0.000 description 1
238000010867 Hoechst staining Methods 0.000 description 1
102100026342 Homeobox protein BarH-like 2 Human genes 0.000 description 1
101001045223 Homo sapiens 17-beta-hydroxysteroid dehydrogenase type 2 Proteins 0.000 description 1
101000928720 Homo sapiens 7-dehydrocholesterol reductase Proteins 0.000 description 1
101000833170 Homo sapiens AF4/FMR2 family member 4 Proteins 0.000 description 1
101000610212 Homo sapiens Adenylyl-sulfate kinase Proteins 0.000 description 1
101000718228 Homo sapiens Adhesion G-protein coupled receptor F1 Proteins 0.000 description 1
101000755890 Homo sapiens Aldehyde dehydrogenase family 3 member B2 Proteins 0.000 description 1
101000703728 Homo sapiens Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 1 Proteins 0.000 description 1
101000889396 Homo sapiens Ankyrin repeat domain-containing protein 1 Proteins 0.000 description 1
101000768069 Homo sapiens Annexin A10 Proteins 0.000 description 1
101000615334 Homo sapiens Antileukoproteinase Proteins 0.000 description 1
101000684459 Homo sapiens Aquaporin-11 Proteins 0.000 description 1
101000798306 Homo sapiens Aurora kinase B Proteins 0.000 description 1
101000887635 Homo sapiens Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 3 Proteins 0.000 description 1
101000897493 Homo sapiens C-C motif chemokine 26 Proteins 0.000 description 1
101000777550 Homo sapiens CCN family member 2 Proteins 0.000 description 1
101000897400 Homo sapiens CD59 glycoprotein Proteins 0.000 description 1
101000914469 Homo sapiens CD82 antigen Proteins 0.000 description 1
101000714537 Homo sapiens Cadherin-2 Proteins 0.000 description 1
101000794587 Homo sapiens Cadherin-5 Proteins 0.000 description 1
101000867855 Homo sapiens Carbonic anhydrase 12 Proteins 0.000 description 1
101000772572 Homo sapiens Carboxypeptidase A4 Proteins 0.000 description 1
101000945881 Homo sapiens Cell migration-inducing and hyaluronan-binding protein Proteins 0.000 description 1
101001099851 Homo sapiens Cellular retinoic acid-binding protein 2 Proteins 0.000 description 1
101000721661 Homo sapiens Cellular tumor antigen p53 Proteins 0.000 description 1
101000880516 Homo sapiens Centrin-2 Proteins 0.000 description 1
101000912659 Homo sapiens Claudin-8 Proteins 0.000 description 1
101000941708 Homo sapiens Collagen alpha-1(V) chain Proteins 0.000 description 1
101000577887 Homo sapiens Collagenase 3 Proteins 0.000 description 1
101000726193 Homo sapiens Cyclic AMP-responsive element-binding protein 5 Proteins 0.000 description 1
101000868333 Homo sapiens Cyclin-dependent kinase 1 Proteins 0.000 description 1
101000614106 Homo sapiens Cytosolic phospholipase A2 gamma Proteins 0.000 description 1
101000909198 Homo sapiens DNA polymerase delta catalytic subunit Proteins 0.000 description 1
101000611567 Homo sapiens DNA primase small subunit Proteins 0.000 description 1
101000928746 Homo sapiens Dehydrogenase/reductase SDR family member 9 Proteins 0.000 description 1
101001053992 Homo sapiens Deleted in lung and esophageal cancer protein 1 Proteins 0.000 description 1
101000864646 Homo sapiens Dickkopf-related protein 1 Proteins 0.000 description 1
101000911787 Homo sapiens Discoidin, CUB and LCCL domain-containing protein 2 Proteins 0.000 description 1
101000777464 Homo sapiens Disintegrin and metalloproteinase domain-containing protein 19 Proteins 0.000 description 1
101000866014 Homo sapiens DnaJ homolog subfamily A member 4 Proteins 0.000 description 1
101000924017 Homo sapiens Dual specificity protein phosphatase 1 Proteins 0.000 description 1
101000881110 Homo sapiens Dual specificity protein phosphatase 12 Proteins 0.000 description 1
101000966403 Homo sapiens Dynein light chain 1, cytoplasmic Proteins 0.000 description 1
101001049692 Homo sapiens E3 SUMO-protein ligase EGR2 Proteins 0.000 description 1
101000848629 Homo sapiens E3 ubiquitin-protein ligase TRIM22 Proteins 0.000 description 1
101000634974 Homo sapiens E3 ubiquitin-protein ligase TRIM31 Proteins 0.000 description 1
101000813745 Homo sapiens ETS translocation variant 5 Proteins 0.000 description 1
101001031752 Homo sapiens FYVE, RhoGEF and PH domain-containing protein 3 Proteins 0.000 description 1
101000892088 Homo sapiens Fibrinogen C domain-containing protein 1 Proteins 0.000 description 1
101000819451 Homo sapiens Frizzled-10 Proteins 0.000 description 1
101001024902 Homo sapiens GRB2-associated-binding protein 2 Proteins 0.000 description 1
101000870644 Homo sapiens Glutamate-cysteine ligase regulatory subunit Proteins 0.000 description 1
101000904259 Homo sapiens Glycerol-3-phosphate acyltransferase 3 Proteins 0.000 description 1
101001058858 Homo sapiens Guanylate-binding protein 2 Proteins 0.000 description 1
101000819109 Homo sapiens H/ACA ribonucleoprotein complex subunit 1 Proteins 0.000 description 1
101001082627 Homo sapiens HLA class II histocompatibility antigen gamma chain Proteins 0.000 description 1
101001037977 Homo sapiens Heat shock 70 kDa protein 1-like Proteins 0.000 description 1
101001037759 Homo sapiens Heat shock 70 kDa protein 1A Proteins 0.000 description 1
101001037968 Homo sapiens Heat shock 70 kDa protein 1B Proteins 0.000 description 1
101001078680 Homo sapiens Heat shock 70 kDa protein 6 Proteins 0.000 description 1
101000866478 Homo sapiens Heat shock protein 105 kDa Proteins 0.000 description 1
101001048053 Homo sapiens Heparan sulfate glucosamine 3-O-sulfotransferase 2 Proteins 0.000 description 1
101001067880 Homo sapiens Histone H4 Proteins 0.000 description 1
101000766187 Homo sapiens Homeobox protein BarH-like 2 Proteins 0.000 description 1
101001081176 Homo sapiens Hyaluronan mediated motility receptor Proteins 0.000 description 1
101100018364 Homo sapiens IGFBP7 gene Proteins 0.000 description 1
101001054830 Homo sapiens Inhibin beta E chain Proteins 0.000 description 1
101001053263 Homo sapiens Insulin gene enhancer protein ISL-1 Proteins 0.000 description 1
101001077600 Homo sapiens Insulin receptor substrate 2 Proteins 0.000 description 1
101001050470 Homo sapiens Intelectin-2 Proteins 0.000 description 1
101001008922 Homo sapiens Kallikrein-11 Proteins 0.000 description 1
101000614627 Homo sapiens Keratin, type I cytoskeletal 13 Proteins 0.000 description 1
101000614439 Homo sapiens Keratin, type I cytoskeletal 15 Proteins 0.000 description 1
101001046960 Homo sapiens Keratin, type II cytoskeletal 1 Proteins 0.000 description 1
101001056452 Homo sapiens Keratin, type II cytoskeletal 6A Proteins 0.000 description 1
101000934758 Homo sapiens Keratin, type II cytoskeletal 72 Proteins 0.000 description 1
101001050567 Homo sapiens Kinesin-like protein KIF2C Proteins 0.000 description 1
101001010513 Homo sapiens Leukocyte elastase inhibitor Proteins 0.000 description 1
101001054876 Homo sapiens Ly-6/neurotoxin-like protein 1 Proteins 0.000 description 1
101000577881 Homo sapiens Macrophage metalloelastase Proteins 0.000 description 1
101000979001 Homo sapiens Methionine aminopeptidase 2 Proteins 0.000 description 1
101000969087 Homo sapiens Microtubule-associated protein 2 Proteins 0.000 description 1
101001055091 Homo sapiens Mitogen-activated protein kinase kinase kinase 8 Proteins 0.000 description 1
101000969770 Homo sapiens Myelin protein zero-like protein 2 Proteins 0.000 description 1
101000637249 Homo sapiens Nexilin Proteins 0.000 description 1
101000973177 Homo sapiens Nuclear factor interleukin-3-regulated protein Proteins 0.000 description 1
101000613969 Homo sapiens Origin recognition complex subunit 1 Proteins 0.000 description 1
101001121324 Homo sapiens Oxidative stress-induced growth inhibitor 1 Proteins 0.000 description 1
101001135738 Homo sapiens Parathyroid hormone-related protein Proteins 0.000 description 1
101000617707 Homo sapiens Pregnancy-specific beta-1-glycoprotein 11 Proteins 0.000 description 1
101000617720 Homo sapiens Pregnancy-specific beta-1-glycoprotein 5 Proteins 0.000 description 1
101000617728 Homo sapiens Pregnancy-specific beta-1-glycoprotein 9 Proteins 0.000 description 1
101000583797 Homo sapiens Protein MCM10 homolog Proteins 0.000 description 1
101000652172 Homo sapiens Protein Smaug homolog 1 Proteins 0.000 description 1
101001122995 Homo sapiens Protein phosphatase 1 regulatory subunit 3C Proteins 0.000 description 1
101000694845 Homo sapiens Protein tyrosine phosphatase domain-containing protein 1 Proteins 0.000 description 1
101001048702 Homo sapiens RNA polymerase II elongation factor ELL2 Proteins 0.000 description 1
101000994788 Homo sapiens Ras GTPase-activating-like protein IQGAP3 Proteins 0.000 description 1
101001060859 Homo sapiens Ras-related protein Rab-32 Proteins 0.000 description 1
101001132698 Homo sapiens Retinoic acid receptor beta Proteins 0.000 description 1
101001106322 Homo sapiens Rho GTPase-activating protein 7 Proteins 0.000 description 1
101000642478 Homo sapiens Serpin B3 Proteins 0.000 description 1
101000869480 Homo sapiens Serum amyloid A-1 protein Proteins 0.000 description 1
101000980900 Homo sapiens Sororin Proteins 0.000 description 1
101000658110 Homo sapiens Synaptotagmin-like protein 2 Proteins 0.000 description 1
101000617808 Homo sapiens Synphilin-1 Proteins 0.000 description 1
101001099181 Homo sapiens TATA-binding protein-associated factor 2N Proteins 0.000 description 1
101000848999 Homo sapiens Tastin Proteins 0.000 description 1
101000666416 Homo sapiens Terminal nucleotidyltransferase 5A Proteins 0.000 description 1
101000844686 Homo sapiens Thioredoxin reductase 1, cytoplasmic Proteins 0.000 description 1
101000785517 Homo sapiens Tight junction protein ZO-3 Proteins 0.000 description 1
101000669460 Homo sapiens Toll-like receptor 5 Proteins 0.000 description 1
101000891367 Homo sapiens Transcobalamin-1 Proteins 0.000 description 1
101000652736 Homo sapiens Transgelin Proteins 0.000 description 1
101000835646 Homo sapiens Tubulin beta-2B chain Proteins 0.000 description 1
101000830596 Homo sapiens Tumor necrosis factor ligand superfamily member 15 Proteins 0.000 description 1
101000823271 Homo sapiens Tyrosine-protein kinase ABL2 Proteins 0.000 description 1
101000607316 Homo sapiens UL-16 binding protein 5 Proteins 0.000 description 1
101000807354 Homo sapiens Ubiquitin-conjugating enzyme E2 C Proteins 0.000 description 1
101000777301 Homo sapiens Uteroglobin Proteins 0.000 description 1
101000670953 Homo sapiens V-type proton ATPase subunit B, kidney isoform Proteins 0.000 description 1
241000701024 Human betaherpesvirus 5 Species 0.000 description 1
102000003918 Hyaluronan Synthases Human genes 0.000 description 1
108090000320 Hyaluronan Synthases Proteins 0.000 description 1
102100027735 Hyaluronan mediated motility receptor Human genes 0.000 description 1
OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical class NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 1
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
WOBHKFSMXKNTIM-UHFFFAOYSA-N Hydroxyethyl methacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 description 1
LCWXJXMHJVIJFK-UHFFFAOYSA-N Hydroxylysine Natural products NCC(O)CC(N)CC(O)=O LCWXJXMHJVIJFK-UHFFFAOYSA-N 0.000 description 1
PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 1
229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
101150028442 IGFBP7 gene Proteins 0.000 description 1
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
108010009817 Immunoglobulin Constant Regions Proteins 0.000 description 1
102000009786 Immunoglobulin Constant Regions Human genes 0.000 description 1
108700005091 Immunoglobulin Genes Proteins 0.000 description 1
102000012745 Immunoglobulin Subunits Human genes 0.000 description 1
108010079585 Immunoglobulin Subunits Proteins 0.000 description 1
208000026350 Inborn Genetic disease Diseases 0.000 description 1
108010034219 Insulin Receptor Substrate Proteins Proteins 0.000 description 1
102100024392 Insulin gene enhancer protein ISL-1 Human genes 0.000 description 1
102100025092 Insulin receptor substrate 2 Human genes 0.000 description 1
102100023352 Intelectin-2 Human genes 0.000 description 1
108010002350 Interleukin-2 Proteins 0.000 description 1
102100023913 Involucrin Human genes 0.000 description 1
102100027612 Kallikrein-11 Human genes 0.000 description 1
102100040487 Keratin, type I cytoskeletal 13 Human genes 0.000 description 1
102100040443 Keratin, type I cytoskeletal 15 Human genes 0.000 description 1
102100022905 Keratin, type II cytoskeletal 1 Human genes 0.000 description 1
102100025656 Keratin, type II cytoskeletal 6A Human genes 0.000 description 1
102100025380 Keratin, type II cytoskeletal 72 Human genes 0.000 description 1
108010070921 Keratin-4 Proteins 0.000 description 1
108010070557 Keratin-6 Proteins 0.000 description 1
102000005706 Keratin-6 Human genes 0.000 description 1
102100023424 Kinesin-like protein KIF2C Human genes 0.000 description 1
238000001276 Kolmogorov–Smirnov test Methods 0.000 description 1
AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 1
150000008575 L-amino acids Chemical class 0.000 description 1
229930182816 L-glutamine Natural products 0.000 description 1
102100034671 L-lactate dehydrogenase A chain Human genes 0.000 description 1
102100024580 L-lactate dehydrogenase B chain Human genes 0.000 description 1
ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
108010088350 Lactate Dehydrogenase 5 Proteins 0.000 description 1
239000005639 Lauric acid Substances 0.000 description 1
108091026898 Leader sequence (mRNA) Proteins 0.000 description 1
ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
102100030635 Leukocyte elastase inhibitor Human genes 0.000 description 1
GDBQQVLCIARPGH-UHFFFAOYSA-N Leupeptin Natural products CC(C)CC(NC(C)=O)C(=O)NC(CC(C)C)C(=O)NC(C=O)CCCN=C(N)N GDBQQVLCIARPGH-UHFFFAOYSA-N 0.000 description 1
208000015673 Lichen planus pemphigoides Diseases 0.000 description 1
239000012097 Lipofectamine 2000 Substances 0.000 description 1
102100026856 Ly-6/neurotoxin-like protein 1 Human genes 0.000 description 1
102100027998 Macrophage metalloelastase Human genes 0.000 description 1
229930195725 Mannitol Natural products 0.000 description 1
244000062730 Melissa officinalis Species 0.000 description 1
235000010654 Melissa officinalis Nutrition 0.000 description 1
102000003792 Metallothionein Human genes 0.000 description 1
108090000157 Metallothionein Proteins 0.000 description 1
206010027476 Metastases Diseases 0.000 description 1
102100023174 Methionine aminopeptidase 2 Human genes 0.000 description 1
102100026907 Mitogen-activated protein kinase kinase kinase 8 Human genes 0.000 description 1
239000004909 Moisturizer Substances 0.000 description 1
241000701029 Murid betaherpesvirus 1 Species 0.000 description 1
241000714177 Murine leukemia virus Species 0.000 description 1
101100509523 Mus musculus Krt6a gene Proteins 0.000 description 1
102100021272 Myelin protein zero-like protein 2 Human genes 0.000 description 1
KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 1
AOMUHOFOVNGZAN-UHFFFAOYSA-N N,N-bis(2-hydroxyethyl)dodecanamide Chemical compound CCCCCCCCCCCC(=O)N(CCO)CCO AOMUHOFOVNGZAN-UHFFFAOYSA-N 0.000 description 1
206010029379 Neutrophilia Diseases 0.000 description 1
102100031801 Nexilin Human genes 0.000 description 1
239000000020 Nitrocellulose Substances 0.000 description 1
102100022163 Nuclear factor interleukin-3-regulated protein Human genes 0.000 description 1
239000004677 Nylon Substances 0.000 description 1
BZQFBWGGLXLEPQ-UHFFFAOYSA-N O-phosphoryl-L-serine Natural products OC(=O)C(N)COP(O)(O)=O BZQFBWGGLXLEPQ-UHFFFAOYSA-N 0.000 description 1
REYJJPSVUYRZGE-UHFFFAOYSA-N Octadecylamine Chemical compound CCCCCCCCCCCCCCCCCCN REYJJPSVUYRZGE-UHFFFAOYSA-N 0.000 description 1
108700026244 Open Reading Frames Proteins 0.000 description 1
102100040591 Origin recognition complex subunit 1 Human genes 0.000 description 1
AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 1
UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 1
102100026320 Oxidative stress-induced growth inhibitor 1 Human genes 0.000 description 1
238000012408 PCR amplification Methods 0.000 description 1
235000019482 Palm oil Nutrition 0.000 description 1
241000282577 Pan troglodytes Species 0.000 description 1
241000282320 Panthera leo Species 0.000 description 1
229930040373 Paraformaldehyde Natural products 0.000 description 1
102100036899 Parathyroid hormone-related protein Human genes 0.000 description 1
206010034016 Paronychia Diseases 0.000 description 1
108010043958 Peptoids Proteins 0.000 description 1
108010000598 Polycomb Repressive Complex 1 Proteins 0.000 description 1
239000004698 Polyethylene Substances 0.000 description 1
101710182846 Polyhedrin Proteins 0.000 description 1
108010039918 Polylysine Proteins 0.000 description 1
241001505332 Polyomavirus sp. Species 0.000 description 1
239000004793 Polystyrene Substances 0.000 description 1
239000004372 Polyvinyl alcohol Substances 0.000 description 1
NPYPAHLBTDXSSS-UHFFFAOYSA-N Potassium ion Chemical compound [K+] NPYPAHLBTDXSSS-UHFFFAOYSA-N 0.000 description 1
102100022025 Pregnancy-specific beta-1-glycoprotein 5 Human genes 0.000 description 1
102100021983 Pregnancy-specific beta-1-glycoprotein 9 Human genes 0.000 description 1
108010065942 Prostaglandin-F synthase Proteins 0.000 description 1
239000004365 Protease Substances 0.000 description 1
102100030962 Protein MCM10 homolog Human genes 0.000 description 1
102100032442 Protein S100-A8 Human genes 0.000 description 1
102100030591 Protein Smaug homolog 1 Human genes 0.000 description 1
102100028506 Protein phosphatase 1 regulatory subunit 3C Human genes 0.000 description 1
102100033947 Protein regulator of cytokinesis 1 Human genes 0.000 description 1
102100028649 Protein tyrosine phosphatase domain-containing protein 1 Human genes 0.000 description 1
UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
102000009572 RNA Polymerase II Human genes 0.000 description 1
108010009460 RNA Polymerase II Proteins 0.000 description 1
238000002123 RNA extraction Methods 0.000 description 1
238000010802 RNA extraction kit Methods 0.000 description 1
102100023750 RNA polymerase II elongation factor ELL2 Human genes 0.000 description 1
230000006819 RNA synthesis Effects 0.000 description 1
239000012980 RPMI-1640 medium Substances 0.000 description 1
102100034417 Ras GTPase-activating-like protein IQGAP3 Human genes 0.000 description 1
102100027915 Ras-related protein Rab-32 Human genes 0.000 description 1
102100030715 Regulator of G-protein signaling 7 Human genes 0.000 description 1
101710140396 Regulator of G-protein signaling 7 Proteins 0.000 description 1
102100033909 Retinoic acid receptor beta Human genes 0.000 description 1
102100021446 Rho GTPase-activating protein 7 Human genes 0.000 description 1
102100027611 Rho-related GTP-binding protein RhoB Human genes 0.000 description 1
101150054980 Rhob gene Proteins 0.000 description 1
102000003661 Ribonuclease III Human genes 0.000 description 1
108010057163 Ribonuclease III Proteins 0.000 description 1
108010003581 Ribulose-bisphosphate carboxylase Proteins 0.000 description 1
108091006305 SLC2A6 Proteins 0.000 description 1
108091006933 SLC39A2 Proteins 0.000 description 1
108091006241 SLC7A11 Proteins 0.000 description 1
101100379220 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) API2 gene Proteins 0.000 description 1
206010039491 Sarcoma Diseases 0.000 description 1
108091081021 Sense strand Proteins 0.000 description 1
238000012300 Sequence Analysis Methods 0.000 description 1
MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
102100036383 Serpin B3 Human genes 0.000 description 1
102100032277 Serum amyloid A-1 protein Human genes 0.000 description 1
102100032007 Serum amyloid A-2 protein Human genes 0.000 description 1
101710083332 Serum amyloid A-2 protein Proteins 0.000 description 1
241000700584 Simplexvirus Species 0.000 description 1
FKNQFGJONOIPTF-UHFFFAOYSA-N Sodium cation Chemical compound [Na+] FKNQFGJONOIPTF-UHFFFAOYSA-N 0.000 description 1
102100022720 Solute carrier family 2, facilitated glucose transporter member 6 Human genes 0.000 description 1
102100024483 Sororin Human genes 0.000 description 1
108091081024 Start codon Proteins 0.000 description 1
VBIIFPGSPJYLRR-UHFFFAOYSA-M Stearyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)C VBIIFPGSPJYLRR-UHFFFAOYSA-M 0.000 description 1
101000879712 Streptomyces lividans Protease inhibitor Proteins 0.000 description 1
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
102100035007 Synaptotagmin-like protein 2 Human genes 0.000 description 1
102100021997 Synphilin-1 Human genes 0.000 description 1
102100038917 TATA-binding protein-associated factor 2N Human genes 0.000 description 1
102000003569 TRPV6 Human genes 0.000 description 1
101150096736 TRPV6 gene Proteins 0.000 description 1
102100034475 Tastin Human genes 0.000 description 1
102100038311 Terminal nucleotidyltransferase 5A Human genes 0.000 description 1
102100031208 Thioredoxin reductase 1, cytoplasmic Human genes 0.000 description 1
AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
239000004473 Threonine Substances 0.000 description 1
102100026640 Tight junction protein ZO-3 Human genes 0.000 description 1
102100039357 Toll-like receptor 5 Human genes 0.000 description 1
229920001615 Tragacanth Polymers 0.000 description 1
102100040396 Transcobalamin-1 Human genes 0.000 description 1
102100031013 Transgelin Human genes 0.000 description 1
239000013504 Triton X-100 Substances 0.000 description 1
229920004890 Triton X-100 Polymers 0.000 description 1
241001504501 Troglodytes Species 0.000 description 1
102100026248 Tubulin beta-2B chain Human genes 0.000 description 1
102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 1
102100024587 Tumor necrosis factor ligand superfamily member 15 Human genes 0.000 description 1
206010054094 Tumour necrosis Diseases 0.000 description 1
102000018472 Type I Keratins Human genes 0.000 description 1
108010091525 Type I Keratins Proteins 0.000 description 1
108010046308 Type II DNA Topoisomerases Proteins 0.000 description 1
102100022651 Tyrosine-protein kinase ABL2 Human genes 0.000 description 1
102100040010 UL-16 binding protein 5 Human genes 0.000 description 1
102100037256 Ubiquitin-conjugating enzyme E2 C Human genes 0.000 description 1
208000024780 Urticaria Diseases 0.000 description 1
102100031083 Uteroglobin Human genes 0.000 description 1
102100039468 V-type proton ATPase subunit B, kidney isoform Human genes 0.000 description 1
KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 1
108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 1
206010052428 Wound Diseases 0.000 description 1
102100025451 Zinc transporter ZIP2 Human genes 0.000 description 1
HIHOWBSBBDRPDW-PTHRTHQKSA-N [(3s,8s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl] n-[2-(dimethylamino)ethyl]carbamate Chemical compound C1C=C2C[C@@H](OC(=O)NCCN(C)C)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HIHOWBSBBDRPDW-PTHRTHQKSA-N 0.000 description 1
RBAKOBGXSDZSNK-UHFFFAOYSA-N [3-bis[3-[dimethyl-[3-(octadecanoylamino)propyl]azaniumyl]-2-hydroxypropoxy]phosphoryloxy-2-hydroxypropyl]-dimethyl-[3-(octadecanoylamino)propyl]azanium trichloride Chemical compound [Cl-].[Cl-].[Cl-].CCCCCCCCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC(O)COP(=O)(OCC(O)C[N+](C)(C)CCCNC(=O)CCCCCCCCCCCCCCCCC)OCC(O)C[N+](C)(C)CCCNC(=O)CCCCCCCCCCCCCCCCC RBAKOBGXSDZSNK-UHFFFAOYSA-N 0.000 description 1
230000005856 abnormality Effects 0.000 description 1
238000005299 abrasion Methods 0.000 description 1
239000003082 abrasive agent Substances 0.000 description 1
206010000269 abscess Diseases 0.000 description 1
230000035508 accumulation Effects 0.000 description 1
238000009825 accumulation Methods 0.000 description 1
DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
238000005903 acid hydrolysis reaction Methods 0.000 description 1
150000007513 acids Chemical class 0.000 description 1
230000009471 action Effects 0.000 description 1
239000000488 activin Substances 0.000 description 1
229960002964 adalimumab Drugs 0.000 description 1
230000000996 additive effect Effects 0.000 description 1
239000001361 adipic acid Substances 0.000 description 1
235000011037 adipic acid Nutrition 0.000 description 1
239000002671 adjuvant Substances 0.000 description 1
239000008272 agar Substances 0.000 description 1
235000010419 agar Nutrition 0.000 description 1
229940040563 agaric acid Drugs 0.000 description 1
238000000246 agarose gel electrophoresis Methods 0.000 description 1
230000032683 aging Effects 0.000 description 1
235000010443 alginic acid Nutrition 0.000 description 1
229920000615 alginic acid Polymers 0.000 description 1
239000000783 alginic acid Substances 0.000 description 1
229960001126 alginic acid Drugs 0.000 description 1
150000004781 alginic acids Chemical class 0.000 description 1
150000001336 alkenes Chemical class 0.000 description 1
125000005907 alkyl ester group Chemical group 0.000 description 1
150000005215 alkyl ethers Chemical class 0.000 description 1
125000002947 alkylene group Chemical group 0.000 description 1
229960000458 allantoin Drugs 0.000 description 1
239000013566 allergen Substances 0.000 description 1
230000000172 allergic effect Effects 0.000 description 1
235000011399 aloe vera Nutrition 0.000 description 1
RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 description 1
230000004075 alteration Effects 0.000 description 1
229940093740 amino acid and derivative Drugs 0.000 description 1
125000006295 amino methylene group Chemical group [H]N(*)C([H])([H])* 0.000 description 1
229920013822 aminosilicone Polymers 0.000 description 1
238000012197 amplification kit Methods 0.000 description 1
229940035676 analgesics Drugs 0.000 description 1
230000003322 aneuploid effect Effects 0.000 description 1
208000036878 aneuploidy Diseases 0.000 description 1
210000004102 animal cell Anatomy 0.000 description 1
239000010775 animal oil Substances 0.000 description 1
239000005557 antagonist Substances 0.000 description 1
239000000730 antalgic agent Substances 0.000 description 1
239000000058 anti acne agent Substances 0.000 description 1
230000003527 anti-angiogenesis Effects 0.000 description 1
230000001772 anti-angiogenic effect Effects 0.000 description 1
230000000844 anti-bacterial effect Effects 0.000 description 1
229940121363 anti-inflammatory agent Drugs 0.000 description 1
239000002260 anti-inflammatory agent Substances 0.000 description 1
230000001028 anti-proliverative effect Effects 0.000 description 1
230000002137 anti-vascular effect Effects 0.000 description 1
229940124340 antiacne agent Drugs 0.000 description 1
229940088710 antibiotic agent Drugs 0.000 description 1
102000025171 antigen binding proteins Human genes 0.000 description 1
108091000831 antigen binding proteins Proteins 0.000 description 1
230000000890 antigenic effect Effects 0.000 description 1
239000003963 antioxidant agent Substances 0.000 description 1
229940030999 antipsoriatics Drugs 0.000 description 1
229940027983 antiseptic and disinfectant quaternary ammonium compound Drugs 0.000 description 1
229960004405 aprotinin Drugs 0.000 description 1
239000003125 aqueous solvent Substances 0.000 description 1
239000008135 aqueous vehicle Substances 0.000 description 1
239000000305 astragalus gummifer gum Substances 0.000 description 1
208000015604 atrophic lichen planus Diseases 0.000 description 1
230000001580 bacterial effect Effects 0.000 description 1
239000003899 bactericide agent Substances 0.000 description 1
230000004888 barrier function Effects 0.000 description 1
108700041737 bcl-2 Genes Proteins 0.000 description 1
WQZGKKKJIJFFOK-FPRJBGLDSA-N beta-D-galactose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-FPRJBGLDSA-N 0.000 description 1
229960003237 betaine Drugs 0.000 description 1
239000012148 binding buffer Substances 0.000 description 1
239000003139 biocide Substances 0.000 description 1
239000013060 biological fluid Substances 0.000 description 1
239000000090 biomarker Substances 0.000 description 1
229920001222 biopolymer Polymers 0.000 description 1
229940036350 bisabolol Drugs 0.000 description 1
HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 description 1
208000002352 blister Diseases 0.000 description 1
230000000903 blocking effect Effects 0.000 description 1
210000004369 blood Anatomy 0.000 description 1
239000008280 blood Substances 0.000 description 1
238000010504 bond cleavage reaction Methods 0.000 description 1
238000010322 bone marrow transplantation Methods 0.000 description 1
210000004556 brain Anatomy 0.000 description 1
239000007853 buffer solution Substances 0.000 description 1
239000004067 bulking agent Substances 0.000 description 1
DHAZIUXMHRHVMP-UHFFFAOYSA-N butyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCCCC DHAZIUXMHRHVMP-UHFFFAOYSA-N 0.000 description 1
210000004899 c-terminal region Anatomy 0.000 description 1
229910000019 calcium carbonate Inorganic materials 0.000 description 1
239000001506 calcium phosphate Substances 0.000 description 1
229910000389 calcium phosphate Inorganic materials 0.000 description 1
235000011010 calcium phosphates Nutrition 0.000 description 1
238000004364 calculation method Methods 0.000 description 1
229960000846 camphor Drugs 0.000 description 1
229930008380 camphor Natural products 0.000 description 1
235000014633 carbohydrates Nutrition 0.000 description 1
229910052799 carbon Inorganic materials 0.000 description 1
239000001569 carbon dioxide Substances 0.000 description 1
229960004424 carbon dioxide Drugs 0.000 description 1
239000001768 carboxy methyl cellulose Substances 0.000 description 1
230000015556 catabolic process Effects 0.000 description 1
230000003197 catalytic effect Effects 0.000 description 1
230000021164 cell adhesion Effects 0.000 description 1
230000024245 cell differentiation Effects 0.000 description 1
230000003915 cell function Effects 0.000 description 1
210000000170 cell membrane Anatomy 0.000 description 1
238000005119 centrifugation Methods 0.000 description 1
229940073669 ceteareth 20 Drugs 0.000 description 1
229940081733 cetearyl alcohol Drugs 0.000 description 1
229960000800 cetrimonium bromide Drugs 0.000 description 1
WOWHHFRSBJGXCM-UHFFFAOYSA-M cetyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+](C)(C)C WOWHHFRSBJGXCM-UHFFFAOYSA-M 0.000 description 1
239000003153 chemical reaction reagent Substances 0.000 description 1
238000002038 chemiluminescence detection Methods 0.000 description 1
210000004978 chinese hamster ovary cell Anatomy 0.000 description 1
238000011098 chromatofocusing Methods 0.000 description 1
238000004587 chromatography analysis Methods 0.000 description 1
230000002759 chromosomal effect Effects 0.000 description 1
210000000349 chromosome Anatomy 0.000 description 1
239000007979 citrate buffer Substances 0.000 description 1
238000004140 cleaning Methods 0.000 description 1
239000013599 cloning vector Substances 0.000 description 1
239000010634 clove oil Substances 0.000 description 1
239000011248 coating agent Substances 0.000 description 1
MRUAUOIMASANKQ-UHFFFAOYSA-N cocamidopropyl betaine Chemical compound CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC([O-])=O MRUAUOIMASANKQ-UHFFFAOYSA-N 0.000 description 1
229940073507 cocamidopropyl betaine Drugs 0.000 description 1
229940110456 cocoa butter Drugs 0.000 description 1
235000019868 cocoa butter Nutrition 0.000 description 1
239000000084 colloidal system Substances 0.000 description 1
208000029742 colonic neoplasm Diseases 0.000 description 1
239000003086 colorant Substances 0.000 description 1
238000011284 combination treatment Methods 0.000 description 1
239000003184 complementary RNA Substances 0.000 description 1
238000009833 condensation Methods 0.000 description 1
230000005494 condensation Effects 0.000 description 1
239000000470 constituent Substances 0.000 description 1
238000007796 conventional method Methods 0.000 description 1
235000005687 corn oil Nutrition 0.000 description 1
239000002285 corn oil Substances 0.000 description 1
239000008120 corn starch Substances 0.000 description 1
229940099112 cornstarch Drugs 0.000 description 1
210000004351 coronary vessel Anatomy 0.000 description 1
230000002596 correlated effect Effects 0.000 description 1
229960001334 corticosteroids Drugs 0.000 description 1
210000004748 cultured cell Anatomy 0.000 description 1
238000012258 culturing Methods 0.000 description 1
230000001351 cycling effect Effects 0.000 description 1
XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
235000018417 cysteine Nutrition 0.000 description 1
125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 1
230000009089 cytolysis Effects 0.000 description 1
231100000135 cytotoxicity Toxicity 0.000 description 1
230000003013 cytotoxicity Effects 0.000 description 1
238000007405 data analysis Methods 0.000 description 1
230000007547 defect Effects 0.000 description 1
230000008260 defense mechanism Effects 0.000 description 1
239000007857 degradation product Substances 0.000 description 1
238000006731 degradation reaction Methods 0.000 description 1
YSMODUONRAFBET-UHFFFAOYSA-N delta-DL-hydroxylysine Natural products NCC(O)CCC(N)C(O)=O YSMODUONRAFBET-UHFFFAOYSA-N 0.000 description 1
239000003398 denaturant Substances 0.000 description 1
238000000326 densiometry Methods 0.000 description 1
238000010511 deprotection reaction Methods 0.000 description 1
239000007933 dermal patch Substances 0.000 description 1
229950006137 dexfosfoserine Drugs 0.000 description 1
206010012601 diabetes mellitus Diseases 0.000 description 1
PXBRQCKWGAHEHS-UHFFFAOYSA-N dichlorodifluoromethane Chemical compound FC(F)(Cl)Cl PXBRQCKWGAHEHS-UHFFFAOYSA-N 0.000 description 1
229940042935 dichlorodifluoromethane Drugs 0.000 description 1
235000019404 dichlorodifluoromethane Nutrition 0.000 description 1
229940087091 dichlorotetrafluoroethane Drugs 0.000 description 1
SICOMXDPFUHNLD-UHFFFAOYSA-N diethyl-[3-(octadecanoylamino)propyl]azanium chloride Chemical compound [Cl-].C(CCCCCCCCCCCCCCCCC)(=O)NCCC[NH+](CC)CC SICOMXDPFUHNLD-UHFFFAOYSA-N 0.000 description 1
ZCPCLAPUXMZUCD-UHFFFAOYSA-M dihexadecyl(dimethyl)azanium;chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCC ZCPCLAPUXMZUCD-UHFFFAOYSA-M 0.000 description 1
239000003085 diluting agent Substances 0.000 description 1
239000000539 dimer Substances 0.000 description 1
DKJLEUVQMKPSHB-UHFFFAOYSA-N dimethyl-[3-(octadecanoylamino)propyl]-(2-oxo-2-tetradecoxyethyl)azanium;chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC(=O)OCCCCCCCCCCCCCC DKJLEUVQMKPSHB-UHFFFAOYSA-N 0.000 description 1
ROSDSFDQCJNGOL-UHFFFAOYSA-O dimethylaminium Chemical compound C[NH2+]C ROSDSFDQCJNGOL-UHFFFAOYSA-O 0.000 description 1
REZZEXDLIUJMMS-UHFFFAOYSA-M dimethyldioctadecylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCCCC REZZEXDLIUJMMS-UHFFFAOYSA-M 0.000 description 1
230000003292 diminished effect Effects 0.000 description 1
MKYNHKOAYQRSBD-UHFFFAOYSA-N dioxouranium;nitric acid Chemical compound O=[U]=O.O[N+]([O-])=O.O[N+]([O-])=O MKYNHKOAYQRSBD-UHFFFAOYSA-N 0.000 description 1
KCIDZIIHRGYJAE-YGFYJFDDSA-L dipotassium;[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] phosphate Chemical compound [K+].[K+].OC[C@H]1O[C@H](OP([O-])([O-])=O)[C@H](O)[C@@H](O)[C@H]1O KCIDZIIHRGYJAE-YGFYJFDDSA-L 0.000 description 1
SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
229940042399 direct acting antivirals protease inhibitors Drugs 0.000 description 1
239000002270 dispersing agent Substances 0.000 description 1
239000004664 distearyldimethylammonium chloride (DHTDMAC) Substances 0.000 description 1
238000009826 distribution Methods 0.000 description 1
PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 1
230000007783 downstream signaling Effects 0.000 description 1
ODQWQRRAPPTVAG-GZTJUZNOSA-N doxepin Chemical compound C1OC2=CC=CC=C2C(=C/CCN(C)C)/C2=CC=CC=C21 ODQWQRRAPPTVAG-GZTJUZNOSA-N 0.000 description 1
238000009510 drug design Methods 0.000 description 1
230000004064 dysfunction Effects 0.000 description 1
230000002900 effect on cell Effects 0.000 description 1
230000003028 elevating effect Effects 0.000 description 1
210000002308 embryonic cell Anatomy 0.000 description 1
230000001159 endocytotic effect Effects 0.000 description 1
239000007920 enema Substances 0.000 description 1
229940079360 enema for constipation Drugs 0.000 description 1
210000000981 epithelium Anatomy 0.000 description 1
YSMODUONRAFBET-UHNVWZDZSA-N erythro-5-hydroxy-L-lysine Chemical compound NC[C@H](O)CC[C@H](N)C(O)=O YSMODUONRAFBET-UHNVWZDZSA-N 0.000 description 1
UYMKPFRHYYNDTL-UHFFFAOYSA-N ethenamine Chemical compound NC=C UYMKPFRHYYNDTL-UHFFFAOYSA-N 0.000 description 1
150000002170 ethers Chemical class 0.000 description 1
LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 description 1
229940093471 ethyl oleate Drugs 0.000 description 1
WBJQGBBEPJLNKP-UHFFFAOYSA-N ethyl-dimethyl-[3-(octadecanoylamino)propyl]azanium;ethyl sulfate Chemical compound CCOS([O-])(=O)=O.CCCCCCCCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC WBJQGBBEPJLNKP-UHFFFAOYSA-N 0.000 description 1
LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
239000010642 eucalyptus oil Substances 0.000 description 1
229940044949 eucalyptus oil Drugs 0.000 description 1
229960002217 eugenol Drugs 0.000 description 1
238000010228 ex vivo assay Methods 0.000 description 1
201000005884 exanthem Diseases 0.000 description 1
230000001747 exhibiting effect Effects 0.000 description 1
238000010195 expression analysis Methods 0.000 description 1
238000000605 extraction Methods 0.000 description 1
239000003925 fat Substances 0.000 description 1
235000019197 fats Nutrition 0.000 description 1
150000002194 fatty esters Chemical class 0.000 description 1
238000000855 fermentation Methods 0.000 description 1
230000004151 fermentation Effects 0.000 description 1
238000001914 filtration Methods 0.000 description 1
239000010419 fine particle Substances 0.000 description 1
239000000834 fixative Substances 0.000 description 1
239000012530 fluid Substances 0.000 description 1
229940028334 follicle stimulating hormone Drugs 0.000 description 1
230000003325 follicular Effects 0.000 description 1
230000004927 fusion Effects 0.000 description 1
238000001641 gel filtration chromatography Methods 0.000 description 1
239000003349 gelling agent Substances 0.000 description 1
238000010363 gene targeting Methods 0.000 description 1
102000034356 gene-regulatory proteins Human genes 0.000 description 1
108091006104 gene-regulatory proteins Proteins 0.000 description 1
208000016361 genetic disease Diseases 0.000 description 1
239000003862 glucocorticoid Substances 0.000 description 1
239000008103 glucose Substances 0.000 description 1
ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
125000005456 glyceride group Chemical group 0.000 description 1
229960001743 golimumab Drugs 0.000 description 1
230000002710 gonadal effect Effects 0.000 description 1
239000003163 gonadal steroid hormone Substances 0.000 description 1
208000024908 graft versus host disease Diseases 0.000 description 1
238000000227 grinding Methods 0.000 description 1
238000009499 grossing Methods 0.000 description 1
230000012010 growth Effects 0.000 description 1
102000028718 growth factor binding proteins Human genes 0.000 description 1
108091009353 growth factor binding proteins Proteins 0.000 description 1
239000013003 healing agent Substances 0.000 description 1
108010037536 heparanase Proteins 0.000 description 1
MZMRZONIDDFOGF-UHFFFAOYSA-M hexadecyl(trimethyl)azanium;4-methylbenzenesulfonate Chemical compound CC1=CC=C(S([O-])(=O)=O)C=C1.CCCCCCCCCCCCCCCC[N+](C)(C)C MZMRZONIDDFOGF-UHFFFAOYSA-M 0.000 description 1
238000013427 histology analysis Methods 0.000 description 1
230000013632 homeostatic process Effects 0.000 description 1
229920001519 homopolymer Polymers 0.000 description 1
230000003054 hormonal effect Effects 0.000 description 1
230000009215 host defense mechanism Effects 0.000 description 1
210000005260 human cell Anatomy 0.000 description 1
238000009396 hybridization Methods 0.000 description 1
229930195733 hydrocarbon Natural products 0.000 description 1
150000002430 hydrocarbons Chemical class 0.000 description 1
239000001257 hydrogen Substances 0.000 description 1
229910052739 hydrogen Inorganic materials 0.000 description 1
238000004191 hydrophobic interaction chromatography Methods 0.000 description 1
QJHBJHUKURJDLG-UHFFFAOYSA-N hydroxy-L-lysine Natural products NCCCCC(NO)C(O)=O QJHBJHUKURJDLG-UHFFFAOYSA-N 0.000 description 1
WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
125000002768 hydroxyalkyl group Chemical group 0.000 description 1
229920013819 hydroxyethyl ethylcellulose Polymers 0.000 description 1
229960002591 hydroxyproline Drugs 0.000 description 1
235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
239000001863 hydroxypropyl cellulose Substances 0.000 description 1
230000006607 hypermethylation Effects 0.000 description 1
208000018371 hypertrophic lichen planus Diseases 0.000 description 1
210000001822 immobilized cell Anatomy 0.000 description 1
229940072221 immunoglobulins Drugs 0.000 description 1
230000002055 immunohistochemical effect Effects 0.000 description 1
238000003364 immunohistochemistry Methods 0.000 description 1
230000001506 immunosuppresive effect Effects 0.000 description 1
229940124589 immunosuppressive drug Drugs 0.000 description 1
238000005462 in vivo assay Methods 0.000 description 1
238000001802 infusion Methods 0.000 description 1
ZPNFWUPYTFPOJU-LPYSRVMUSA-N iniprol Chemical compound C([C@H]1C(=O)NCC(=O)NCC(=O)N[C@H]2CSSC[C@H]3C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(N[C@H](C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC=4C=CC=CC=4)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC=4C=CC=CC=4)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC2=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H]2N(CCC2)C(=O)[C@@H](N)CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N2[C@@H](CCC2)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N2[C@@H](CCC2)C(=O)N3)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@H](C(=O)N1)C(C)C)[C@@H](C)O)[C@@H](C)CC)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 ZPNFWUPYTFPOJU-LPYSRVMUSA-N 0.000 description 1
230000002608 insulinlike Effects 0.000 description 1
230000002452 interceptive effect Effects 0.000 description 1
238000003046 intermediate neglect of differential overlap Methods 0.000 description 1
230000000968 intestinal effect Effects 0.000 description 1
238000007918 intramuscular administration Methods 0.000 description 1
238000007912 intraperitoneal administration Methods 0.000 description 1
238000007913 intrathecal administration Methods 0.000 description 1
238000001990 intravenous administration Methods 0.000 description 1
238000007914 intraventricular administration Methods 0.000 description 1
238000011835 investigation Methods 0.000 description 1
102000007236 involucrin Human genes 0.000 description 1
238000004255 ion exchange chromatography Methods 0.000 description 1
239000002085 irritant Substances 0.000 description 1
231100000021 irritant Toxicity 0.000 description 1
230000007794 irritation Effects 0.000 description 1
RGXCTRIQQODGIZ-UHFFFAOYSA-O isodesmosine Chemical compound OC(=O)C(N)CCCC[N+]1=CC(CCC(N)C(O)=O)=CC(CCC(N)C(O)=O)=C1CCCC(N)C(O)=O RGXCTRIQQODGIZ-UHFFFAOYSA-O 0.000 description 1
FZWBNHMXJMCXLU-BLAUPYHCSA-N isomaltotriose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)O1 FZWBNHMXJMCXLU-BLAUPYHCSA-N 0.000 description 1
230000003780 keratinization Effects 0.000 description 1
238000002372 labelling Methods 0.000 description 1
239000004922 lacquer Substances 0.000 description 1
108010087599 lactate dehydrogenase 1 Proteins 0.000 description 1
229940099367 lanolin alcohols Drugs 0.000 description 1
230000002045 lasting effect Effects 0.000 description 1
229940031957 lauric acid diethanolamide Drugs 0.000 description 1
208000032839 leukemia Diseases 0.000 description 1
108010052968 leupeptin Proteins 0.000 description 1
GDBQQVLCIARPGH-ULQDDVLXSA-N leupeptin Chemical compound CC(C)C[C@H](NC(C)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C=O)CCCN=C(N)N GDBQQVLCIARPGH-ULQDDVLXSA-N 0.000 description 1
208000014048 linear lichen planus Diseases 0.000 description 1
239000000865 liniment Substances 0.000 description 1
239000004973 liquid crystal related substance Substances 0.000 description 1
229940057995 liquid paraffin Drugs 0.000 description 1
238000011068 loading method Methods 0.000 description 1
239000007937 lozenge Substances 0.000 description 1
239000000314 lubricant Substances 0.000 description 1
206010025135 lupus erythematosus Diseases 0.000 description 1
210000002540 macrophage Anatomy 0.000 description 1
235000019359 magnesium stearate Nutrition 0.000 description 1
238000000838 magnetophoresis Methods 0.000 description 1
FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 description 1
210000004216 mammary stem cell Anatomy 0.000 description 1
239000000594 mannitol Substances 0.000 description 1
235000010355 mannitol Nutrition 0.000 description 1
238000005259 measurement Methods 0.000 description 1
230000007246 mechanism Effects 0.000 description 1
210000002752 melanocyte Anatomy 0.000 description 1
201000001441 melanoma Diseases 0.000 description 1
229940041616 menthol Drugs 0.000 description 1
230000004060 metabolic process Effects 0.000 description 1
229910052751 metal Inorganic materials 0.000 description 1
239000002184 metal Substances 0.000 description 1
230000009401 metastasis Effects 0.000 description 1
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
229940057867 methyl lactate Drugs 0.000 description 1
XJRBAMWJDBPFIM-UHFFFAOYSA-N methyl vinyl ether Chemical compound COC=C XJRBAMWJDBPFIM-UHFFFAOYSA-N 0.000 description 1
239000000693 micelle Substances 0.000 description 1
238000002493 microarray Methods 0.000 description 1
230000002906 microbiologic effect Effects 0.000 description 1
244000005700 microbiome Species 0.000 description 1
238000000520 microinjection Methods 0.000 description 1
239000011859 microparticle Substances 0.000 description 1
230000003278 mimic effect Effects 0.000 description 1
230000002297 mitogenic effect Effects 0.000 description 1
230000001333 moisturizer Effects 0.000 description 1
238000012544 monitoring process Methods 0.000 description 1
239000000178 monomer Substances 0.000 description 1
210000005087 mononuclear cell Anatomy 0.000 description 1
210000002200 mouth mucosa Anatomy 0.000 description 1
230000035772 mutation Effects 0.000 description 1
108700021654 myb Genes Proteins 0.000 description 1
125000001421 myristyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
WWVIUVHFPSALDO-UHFFFAOYSA-N n-[3-(dimethylamino)propyl]octadecanamide Chemical compound CCCCCCCCCCCCCCCCCC(=O)NCCCN(C)C WWVIUVHFPSALDO-UHFFFAOYSA-N 0.000 description 1
ALQWDAJTEFASRJ-UHFFFAOYSA-N n-hexadecylhexadecan-1-amine;hydrochloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[NH2+]CCCCCCCCCCCCCCCC ALQWDAJTEFASRJ-UHFFFAOYSA-N 0.000 description 1
239000006199 nebulizer Substances 0.000 description 1
230000014399 negative regulation of angiogenesis Effects 0.000 description 1
230000006654 negative regulation of apoptotic process Effects 0.000 description 1
230000035407 negative regulation of cell proliferation Effects 0.000 description 1
230000001613 neoplastic effect Effects 0.000 description 1
238000006386 neutralization reaction Methods 0.000 description 1
230000003472 neutralizing effect Effects 0.000 description 1
210000000440 neutrophil Anatomy 0.000 description 1
229920001220 nitrocellulos Polymers 0.000 description 1
229910052757 nitrogen Inorganic materials 0.000 description 1
210000000633 nuclear envelope Anatomy 0.000 description 1
238000007899 nucleic acid hybridization Methods 0.000 description 1
210000004940 nucleus Anatomy 0.000 description 1
230000035764 nutrition Effects 0.000 description 1
235000016709 nutrition Nutrition 0.000 description 1
229920001778 nylon Polymers 0.000 description 1
235000014593 oils and fats Nutrition 0.000 description 1
238000002515 oligonucleotide synthesis Methods 0.000 description 1
239000004006 olive oil Substances 0.000 description 1
235000008390 olive oil Nutrition 0.000 description 1
238000011275 oncology therapy Methods 0.000 description 1
210000003250 oocyst Anatomy 0.000 description 1
239000003605 opacifier Substances 0.000 description 1
239000003791 organic solvent mixture Substances 0.000 description 1
229960003104 ornithine Drugs 0.000 description 1
239000001301 oxygen Substances 0.000 description 1
229910052760 oxygen Inorganic materials 0.000 description 1
239000002540 palm oil Substances 0.000 description 1
125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
229940101267 panthenol Drugs 0.000 description 1
235000019161 pantothenic acid Nutrition 0.000 description 1
229940055726 pantothenic acid Drugs 0.000 description 1
239000011713 pantothenic acid Substances 0.000 description 1
235000020957 pantothenol Nutrition 0.000 description 1
239000011619 pantothenol Substances 0.000 description 1
229940055729 papain Drugs 0.000 description 1
235000019834 papain Nutrition 0.000 description 1
239000012188 paraffin wax Substances 0.000 description 1
229920002866 paraformaldehyde Polymers 0.000 description 1
230000007310 pathophysiology Effects 0.000 description 1
108010043655 penetratin Proteins 0.000 description 1
MCYTYTUNNNZWOK-LCLOTLQISA-N penetratin Chemical compound C([C@H](NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CCCNC(N)=N)[C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O)C1=CC=CC=C1 MCYTYTUNNNZWOK-LCLOTLQISA-N 0.000 description 1
239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
231100000435 percutaneous penetration Toxicity 0.000 description 1
210000003819 peripheral blood mononuclear cell Anatomy 0.000 description 1
238000002823 phage display Methods 0.000 description 1
150000004713 phosphodiesters Chemical class 0.000 description 1
BZQFBWGGLXLEPQ-REOHCLBHSA-N phosphoserine Chemical compound OC(=O)[C@@H](N)COP(O)(O)=O BZQFBWGGLXLEPQ-REOHCLBHSA-N 0.000 description 1
USRGIUJOYOXOQJ-GBXIJSLDSA-N phosphothreonine Chemical compound OP(=O)(O)O[C@H](C)[C@H](N)C(O)=O USRGIUJOYOXOQJ-GBXIJSLDSA-N 0.000 description 1
230000004962 physiological condition Effects 0.000 description 1
239000006187 pill Substances 0.000 description 1
239000004014 plasticizer Substances 0.000 description 1
229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
229920001515 polyalkylene glycol Polymers 0.000 description 1
229920000768 polyamine Polymers 0.000 description 1
229920000728 polyester Polymers 0.000 description 1
229920000573 polyethylene Polymers 0.000 description 1
229920000656 polylysine Polymers 0.000 description 1
238000003752 polymerase chain reaction Methods 0.000 description 1
239000004926 polymethyl methacrylate Substances 0.000 description 1
229920005862 polyol Polymers 0.000 description 1
150000003077 polyols Chemical class 0.000 description 1
229920000136 polysorbate Polymers 0.000 description 1
229920002223 polystyrene Polymers 0.000 description 1
229920002451 polyvinyl alcohol Polymers 0.000 description 1
230000004481 post-translational protein modification Effects 0.000 description 1
229910001414 potassium ion Inorganic materials 0.000 description 1
229920001592 potato starch Polymers 0.000 description 1
229940116317 potato starch Drugs 0.000 description 1
230000003389 potentiating effect Effects 0.000 description 1
239000002244 precipitate Substances 0.000 description 1
230000002335 preservative effect Effects 0.000 description 1
108091007428 primary miRNA Proteins 0.000 description 1
230000000750 progressive effect Effects 0.000 description 1
210000001236 prokaryotic cell Anatomy 0.000 description 1
XJMOSONTPMZWPB-UHFFFAOYSA-M propidium iodide Chemical compound [I-].[I-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CCC[N+](C)(CC)CC)=C1C1=CC=CC=C1 XJMOSONTPMZWPB-UHFFFAOYSA-M 0.000 description 1
BTAXGNQLYFDKEF-UHFFFAOYSA-N propyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCC BTAXGNQLYFDKEF-UHFFFAOYSA-N 0.000 description 1
DPBVJRXPSXTHOL-UHFFFAOYSA-N propyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCCC DPBVJRXPSXTHOL-UHFFFAOYSA-N 0.000 description 1
125000006239 protecting group Chemical group 0.000 description 1
230000001681 protective effect Effects 0.000 description 1
238000012514 protein characterization Methods 0.000 description 1
230000009145 protein modification Effects 0.000 description 1
239000002510 pyrogen Substances 0.000 description 1
150000004040 pyrrolidinones Chemical class 0.000 description 1
238000004445 quantitative analysis Methods 0.000 description 1
238000003762 quantitative reverse transcription PCR Methods 0.000 description 1
150000003856 quaternary ammonium compounds Chemical class 0.000 description 1
125000001453 quaternary ammonium group Chemical group 0.000 description 1
230000005855 radiation Effects 0.000 description 1
206010037844 rash Diseases 0.000 description 1
239000011541 reaction mixture Substances 0.000 description 1
238000003753 real-time PCR Methods 0.000 description 1
230000008707 rearrangement Effects 0.000 description 1
238000010188 recombinant method Methods 0.000 description 1
230000025915 regulation of apoptotic process Effects 0.000 description 1
230000029219 regulation of pH Effects 0.000 description 1
230000008844 regulatory mechanism Effects 0.000 description 1
230000000241 respiratory effect Effects 0.000 description 1
230000003938 response to stress Effects 0.000 description 1
230000004043 responsiveness Effects 0.000 description 1
238000004366 reverse phase liquid chromatography Methods 0.000 description 1
230000002441 reversible effect Effects 0.000 description 1
229940100486 rice starch Drugs 0.000 description 1
238000007363 ring formation reaction Methods 0.000 description 1
229920002477 rna polymer Polymers 0.000 description 1
239000000932 sedative agent Substances 0.000 description 1
230000001624 sedative effect Effects 0.000 description 1
238000010187 selection method Methods 0.000 description 1
239000003352 sequestering agent Substances 0.000 description 1
239000008159 sesame oil Substances 0.000 description 1
235000011803 sesame oil Nutrition 0.000 description 1
230000035939 shock Effects 0.000 description 1
239000013605 shuttle vector Substances 0.000 description 1
230000001743 silencing effect Effects 0.000 description 1
238000007390 skin biopsy Methods 0.000 description 1
231100000245 skin permeability Toxicity 0.000 description 1
239000002002 slurry Substances 0.000 description 1
239000000344 soap Substances 0.000 description 1
239000011734 sodium Substances 0.000 description 1
229910052708 sodium Inorganic materials 0.000 description 1
235000015424 sodium Nutrition 0.000 description 1
235000010413 sodium alginate Nutrition 0.000 description 1
239000000661 sodium alginate Substances 0.000 description 1
229940005550 sodium alginate Drugs 0.000 description 1
235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
239000001509 sodium citrate Substances 0.000 description 1
NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
229910001415 sodium ion Inorganic materials 0.000 description 1
239000012439 solid excipient Substances 0.000 description 1
239000002047 solid lipid nanoparticle Substances 0.000 description 1
238000005063 solubilization Methods 0.000 description 1
230000007928 solubilization Effects 0.000 description 1
230000000392 somatic effect Effects 0.000 description 1
230000037439 somatic mutation Effects 0.000 description 1
239000003549 soybean oil Substances 0.000 description 1
235000012424 soybean oil Nutrition 0.000 description 1
230000019100 sperm motility Effects 0.000 description 1
238000003153 stable transfection Methods 0.000 description 1
239000012192 staining solution Substances 0.000 description 1
238000007619 statistical method Methods 0.000 description 1
125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
210000000130 stem cell Anatomy 0.000 description 1
239000008223 sterile water Substances 0.000 description 1
238000003860 storage Methods 0.000 description 1
238000007920 subcutaneous administration Methods 0.000 description 1
150000003462 sulfoxides Chemical class 0.000 description 1
239000000516 sunscreening agent Substances 0.000 description 1
239000006228 supernatant Substances 0.000 description 1
239000000829 suppository Substances 0.000 description 1
239000002511 suppository base Substances 0.000 description 1
230000004083 survival effect Effects 0.000 description 1
239000000375 suspending agent Substances 0.000 description 1
230000002459 sustained effect Effects 0.000 description 1
208000011580 syndromic disease Diseases 0.000 description 1
239000006188 syrup Substances 0.000 description 1
235000020357 syrup Nutrition 0.000 description 1
229940037128 systemic glucocorticoids Drugs 0.000 description 1
238000009121 systemic therapy Methods 0.000 description 1
150000003505 terpenes Chemical class 0.000 description 1
235000007586 terpenes Nutrition 0.000 description 1
229940124597 therapeutic agent Drugs 0.000 description 1
125000003396 thiol group Chemical group [H]S* 0.000 description 1
150000003573 thiols Chemical class 0.000 description 1
RYYWUUFWQRZTIU-UHFFFAOYSA-K thiophosphate Chemical compound [O-]P([O-])([O-])=S RYYWUUFWQRZTIU-UHFFFAOYSA-K 0.000 description 1
239000004408 titanium dioxide Substances 0.000 description 1
FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 1
230000005026 transcription initiation Effects 0.000 description 1
230000037317 transdermal delivery Effects 0.000 description 1
230000001052 transient effect Effects 0.000 description 1
238000003146 transient transfection Methods 0.000 description 1
230000014621 translational initiation Effects 0.000 description 1
230000005945 translocation Effects 0.000 description 1
238000011269 treatment regimen Methods 0.000 description 1
150000003626 triacylglycerols Chemical class 0.000 description 1
QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
CYRMSUTZVYGINF-UHFFFAOYSA-N trichlorofluoromethane Chemical compound FC(Cl)(Cl)Cl CYRMSUTZVYGINF-UHFFFAOYSA-N 0.000 description 1
229940029284 trichlorofluoromethane Drugs 0.000 description 1
UZNHKBFIBYXPDV-UHFFFAOYSA-N trimethyl-[3-(2-methylprop-2-enoylamino)propyl]azanium;chloride Chemical compound [Cl-].CC(=C)C(=O)NCCC[N+](C)(C)C UZNHKBFIBYXPDV-UHFFFAOYSA-N 0.000 description 1
GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 1
229960001005 tuberculin Drugs 0.000 description 1
230000005740 tumor formation Effects 0.000 description 1
108010086502 tumor-derived adhesion factor Proteins 0.000 description 1
231100000397 ulcer Toxicity 0.000 description 1
238000002604 ultrasonography Methods 0.000 description 1
239000006097 ultraviolet radiation absorber Substances 0.000 description 1
230000004906 unfolded protein response Effects 0.000 description 1
241000701447 unidentified baculovirus Species 0.000 description 1
241001515965 unidentified phage Species 0.000 description 1
210000002700 urine Anatomy 0.000 description 1
229960003824 ustekinumab Drugs 0.000 description 1
238000010200 validation analysis Methods 0.000 description 1
239000004474 valine Substances 0.000 description 1
210000003556 vascular endothelial cell Anatomy 0.000 description 1
235000013311 vegetables Nutrition 0.000 description 1
230000002861 ventricular Effects 0.000 description 1
108700026220 vif Genes Proteins 0.000 description 1
230000016776 visual perception Effects 0.000 description 1
150000003722 vitamin derivatives Chemical class 0.000 description 1
239000000341 volatile oil Substances 0.000 description 1
239000002699 waste material Substances 0.000 description 1
229920003169 water-soluble polymer Polymers 0.000 description 1
229940100445 wheat starch Drugs 0.000 description 1
230000029663 wound healing Effects 0.000 description 1
235000010493 xanthan gum Nutrition 0.000 description 1
239000000230 xanthan gum Substances 0.000 description 1
229920001285 xanthan gum Polymers 0.000 description 1
229940082509 xanthan gum Drugs 0.000 description 1